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ABSTRACT
Background: The Affordable Care Act (ACA) waived deductibles and eliminated 
coinsurance for colonoscopies for Medicare beneficiaries beginning on January 1, 2011. 
This study investigated the effect of the ACA’s removing of financial barriers on the 
receipt of colonoscopies among insured elderly, who are predominantly covered by 
Medicare. Moreover, this study examined how income-related disparities in colonoscopy 
use have changed over the past decade and attempted to quantify various contributions to 
income-related disparity in the use of colonoscopies among insured elderly. 
Methods: Five cycles (2008, 2010, 2012, 2014, and 2016) of the Behavioral Risk Factor 
Surveillance System (BRFSS) were utilized to examine the receipt of colonoscopies 
among insured elderly aged 65 to 75 prior to the implementation of ACA and then again 
afterwards. To examine income-related disparities in the use of colonoscopies, 
individuals aged 65 to 75 were included, and the Concentration Index (CI) was calculated 
before and after implementation of the ACA. To identify and quantify the contribution of 
each factor, decomposition of the CIs was conducted. 
Results: Of 349,899 eligible elderly insured in the age group 65 to 75 years, 236,275 
(68%) had received a colonoscopy in the previous 10 years. The receipt of colonoscopies 
increased from 63% in the pre-ACA years to 70% in the post-ACA years (p<.001). 
Compared with the pre-ACA period, colonoscopy uptake during post-ACA years shows 
an odds ratio of 1.15 (95% confidence limit [CI] = 1.08-1.22, p<.001) after adjusting for 
vi 
time dependent improvements in colonoscopies and other relevant factors. CIs indicated 
that disparities in colonoscopy use were lessened after the implementation of the ACA. 
Decomposition analyses showed that whereas decreases in disparities derived largely 
from income and educational levels, higher levels of income and educational attainment 
continue to be major contributors to the observed disparities in colonoscopy use.   
Conclusions: Following the implementation of the ACA, a statistically significant 
increases in colonoscopy use was observed and may contribute to the observed decreases 
in the disparity of colonoscopy use. This suggests that eliminating financial barriers to 
access has improved the CRC screening rate, but achieving the national goal of 80% 
coverage and the Healthy People 2020 goal will require additional interventions to 
encourage higher screening levels.
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Colorectal cancer (CRC) is the second leading cause of cancer deaths for both 
men and women in the United States (Siegel, Miller et al. 2017). There were an estimated 
135,430 new cases and 50,260 deaths from CRC in 2017 (Siegel, Miller et al. 2017).  
Early detection of CRC through routine screening has been demonstrated to be effective 
in reducing the incidence of and mortality from this disease (Edwards, Ward et al. 2010, 
Lin, Piper et al. 2016, Siegel, Miller et al. 2017). The U.S. Preventive Services Task 
Force (USPSTF) strongly recommends screening for CRC beginning at the age of 50 and 
continuing until the age of 75 for individuals at average risk, implying that increases in 
screening for CRC result in decreases for CRC mortality (Koretz 2016, Lin, Piper et al. 
2016, US Preventive Services Task Force 2016).  
USPSTF has recommended a  number of different screening tests for use in 
detecting early-stage CRC and preventing incident cases, including 1) flexible 
sigmoidoscopy every 5 years, 2) FIT-DNA every 1 or 3 years, 3) fecal occult blood test 
or fecal immunochemical testing every year, 4) CT colonography every 5 years, 5) 
flexible sigmoidoscopy every 10 years plus FIT every year, and (6) colonoscopy every 10 
years (US Preventive Services Task Force 2016). The USPSTF recommends screening 
using any of the accepted methods, as any type of screening test would be better than no 
screening at all (Atkin, Edwards et al. 2010, Quintero, Castells et al. 2012, Patel and 
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Kilgore 2015, US Preventive Services Task Force 2016). All the screening options are 
not equally attractive to all individuals; depending upon health history and preferences of 
individuals, the choices may differ significantly. However, from a clinical perspective, 
colonoscopy is the preferred method, because a colonoscopy allows doctors to examine 
the entire length of the colon and remove all cancers and precancerous polyps during a 
single procedure (Levin, Lieberman et al. 2008, Rex, Johnson et al. 2009, Wolf, Basch et 
al. 2016). Colonoscopy is also recommended as a follow-up when another CRC screening 
is positive. Moreover, colonoscopy has been validated in a randomized trial to have a 
mortality reduction benefit  (Zauber, Winawer et al. 2012, Patel and Kilgore 2015, Koretz 
2016, US Preventive Services Task Force 2016).  
The mortality rate from CRC has decreased steadily since 1980 (Weir, Thompson 
et al. 2015, Siegel, Miller et al. 2017), which may be attributable partially to removal of 
pre-cancerous, adenomatous polyps at an early stage based on diagnosis of CRC and 
partially to widespread use of colonoscopies or other screening approaches (Cunningham, 
Atkin et al. 2010, Edwards, Ward et al. 2010, Lieberman 2010, Martin, Tully et al. 2017, 
Partin, Gravely et al. 2017). Nonetheless, self-reported CRC screening rates in the 
National Health Interview Survey are at 62%, and the National Committee for Quality 
Assurance (NCQA) indicates that 60% of commercial insurance members and 69% of 
Medicare plan members received an appropriate CRC screening in 2016 (Paskett and 
Khuri 2015, White, Thompson et al. 2017). Moreover, Behavioral Risk Factor 
Surveillance System (BRFSS) data indicate that around 65% of adults aged 50 to 75 
reported having had one of the colorectal screening tests recommended by USPSTF, and 
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around 60% of adults aged 50 to 75 had received a colonoscopy within the last 10 years 
(Joseph, King et al. 2012, Liss and Baker 2014).  
The US Department of Health and Human Services (HHS) initiated Healthy 
People 2020 (HP2020), which covered several objectives for reducing cancer mortality. 
Each objective was assigned a baseline measure in 2007 and a target to be achieved by 
2020. HP2020 calls for a 15% reduction in death rates from 2007 to 2020 for CRC (Weir, 
Thompson et al. 2015). Moreover, the National Colorectal Cancer Roundtable (NCCRT) 
initiated a goal to increase the CRC screening rate to 80% in the eligible population by 
2018 (Karlitz, Oliphant et al. 2017). Achieving this goal would avert 280,000 new cases 
of CRC and 200,000 deaths from the disease by 2030, and 24.4 million people would be 
screened (Fedewa, Ma et al. 2015, Meester, Doubeni et al. 2015). Nonetheless, the 
aforementioned screening rates are lower than the use of preventive interventions for 
other screening-amenable cancers, below the 80% coverage of the CRC screening target, 
and below the HP2020 target of 71% (Swan, Breen et al. 2010, Karlitz, Oliphant et al. 
2017, White, Thompson et al. 2017).  
One potential barrier to CRC screening is the associated out-of-pocket financial 
costs (Howard, Guy et al. 2014). The financial costs may significantly dampen patients’ 
willingness to adopt any preventive procedures, including any of the recommended CRC 
screenings. This is especially true for colonoscopies, which usually involved relatively 
high cost-sharing requirements prior to the ACA policy change in 2011 (Klabunde, Riley 
et al. 2004, Hamman and Kapinos 2015). Previous studies have shown that cost-sharing 
reduces preventive health care use, including the use of highly effective screening tests 
(Busch, Barry et al. 2006, Goodwin and Anderson 2012). One study found that waiving 
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coinsurance for colonoscopies resulted in an 18% increase in screenings (Khatami, Xuan 
et al. 2012). 
To address the negative consequences of financial barriers on the use of 
preventive services and to promote CRC screening, the Affordable Care Act (ACA) 
requires all non-grandfathered private health plans to offer coverage of CRC screening 
without cost-sharing. Consistent with the ACA policy requirement, beginning January 1, 
2011, Medicare waived Part B deductibles for all colonoscopies and eliminated 
coinsurance for screening colonoscopies, although not for diagnostic ones (Howard, Guy 
et al. 2014, Hamman and Kapinos 2015). Therefore, Medicare beneficiaries may face 
unexpected out-of-pocket liabilities when a polyp is detected and removed during a 
colonoscopy, in which case the patients are billed a copay. Medicare beneficiaries are 
also responsible for Part B deductibles and coinsurance when a colonoscopy is performed 
as part of a two-step screening process after another CRC screening is positive (Howard, 
Guy et al. 2014). Nevertheless, the ACA policy change, in general, implies that the 
elderly insured population should see significant reductions in out-of-pocket expenses 
associated with colonoscopies. 
Research on the effects of cost-sharing reductions to utilization of preventive 
health care has received significant attention from researchers and policy makers; but 
surprisingly, only a few studies have assessed the effect of cost-sharing reduction on 
colonoscopies among the elderly insured population, including the Medicare 
beneficiaries, following the implementation of the ACA (Hamman and Kapinos 2015, 
Cooper, Kou et al. 2016). The few studies that have examined this issue used a very short 
time-frame beginning with the implementation of the ACA, so they may have 
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underestimated the effects of the ACA cost-sharing reduction. Furthermore, these studies 
yielded variable results concerning the receipt of colonoscopies following the changes in 
coverage post-ACA (Fedewa, Goodman et al. 2015, Hamman and Kapinos 2015, Cooper, 
Kou et al. 2016); and they have not been able to determine whether eliminating financial 
barriers might have helped socioeconomically vulnerable Medicare beneficiaries more 
than other groups. Moreover, these studies have not examined the ACA’s impact on 
screening disparities among the elderly insured. It is true that some of the 
socioeconomically vulnerable elderly may be enrolled in Medicaid; and in that case, 
these individuals would have received colonoscopies with no out-of-pocket expenses in 
the pre-ACA years. However, this should not affect the results significantly as almost all 
elderly are enrolled in Medicare and only a relatively small percentage are enrolled in 
Medicaid (Medicaid only or dually eligible) (Grabowski, 2012).  
Thus, to address these gaps in current research, this study aimed to examine the 
changes in colonoscopy use among the elderly insured population, including Medicare 
beneficiaries, following the implementation of the ACA policy for preventive services. 
Our hypothesis was that the elderly insured population have a greater likelihood of 
undergoing colonoscopies following the implementation of the ACA. We also wanted to 
determine whether the ACA policy changes have helped the socioeconomically 
vulnerable elderly more than others. 
This study consists of two manuscripts. The first manuscript of the dissertation 
examined the effect of the ACA cost-sharing reduction on the receipt of colonoscopy 
among the elderly insured population. This study aimed to examine how the ACA cost-
sharing reduction has changed colonoscopy use among the elderly insured and to assess 
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the various factors that affect the receipt of colonoscopies. The second manuscript 
examined how disparities in colonoscopy use in the United States have changed over the 
past decade, in line with the implementation of the ACA and attempted to quantify the 
contributions to the disparity in the use of colonoscopies among elderly insured.    
The dissertation is organized into five chapters, including two manuscripts. 
Chapter 1 provides the background information and the rationale of the study. Chapter 2 
describes a review of the scientific literature that provides a current understanding of 
colorectal cancer screening and of efforts to improve colorectal cancer screening. 
Knowledge gaps are also stated. Chapter 3 presents the methodology of the study. 
Chapter 4 presents the two manuscripts. Chapter 5 includes the overall discussion, 












BACKGROUND AND SIGNIFICANCE 
 
 
2.1 Colorectal Cancer 
Colorectal cancer (CRC) is a type of cancer that develops in the colon or rectum, 
and over two thirds of CRCs in the United States are found in the colon (Murphy, Harlan 
et al. 2015). Most forms of CRC grow slowly over a decade or more. CRC symptoms 
depend on the location and size of the cancer. Prior studies have shown that symptoms, 
such as changes in bowel habits, changes in stool consistency, blood in the stool, rectal 
bleeding, abdominal discomfort, and unintended weight loss, are associated with CRC; 
but they are also common in individuals without cancer, which indicates poor sensitivity 
in self-diagnosis of CRC (Jellema, van der Windt et al. 2010, Astin, Griffin et al. 2011, 
Williams, Cubiella et al. 2016). Symptoms alone cannot be the determinant of CRC; 
therefore, identifying patients who should be referred for diagnostic colonoscopy remains 
a challenge (Williams, Cubiella et al. 2016).    
There were an estimated 135,430 new cases of and 50,260 deaths from CRC in 
2017 (Siegel, Miller et al. 2017). Although the majority of new cases develop in people 
aged 65 or older, 45% of men and 39% of women are younger than age 65 years old at 




develop in those aged 80 or older, compared with 27% of cases and 40% of deaths, 
respectively, among women (Siegel, Miller et al. 2017). The mean age at death from 
CRC is 73 years (US Preventive Services Task Force 2016). Incidence and mortality rates 
have been decreasing for several decades as a consequence of historical changes in risk 
factors, the introduction and dissemination of screening tests, and advancements in 
treatment (Edwards, Ward et al. 2010, Lin, Piper et al. 2016, Martin, Tully et al. 2017). 
CRC is the third most commonly diagnosed malignancy and the second leading 
cause of cancer deaths for both men and women in the United States (Siegel, Miller et al. 
2017). From 2009-2013, the annual age-standardized incidence rate for CRC in the 
United States was 41 per 100,000 persons, and from 2010-2014 the mortality rate was 15 
per 100,000 persons (Siegel, Miller et al. 2017). Despite the fact that the lifetime risk of 
disease is no different in men (5%) than in women (4%), the incidence rate was 30% 
higher in men, and the mortality rate was 40% higher in men (Siegel, Miller et al. 2017). 
Sex disparities also vary by age. For example, the incidence rate was 132 per 100,000 
men aged 55 to 74 years and 91 per 100,000 women aged 55 to 74 years (Siegel, Miller et 
al. 2017). The higher rates in men can be explained by differences in exposures to risk 
factors and sex hormones, as well as complex interactions between these forces (Murphy, 
Devesa et al. 2011).   
CRC incidence and mortality rates differ considerably by race and ethnicity 
(Siegel, Miller et al. 2017). Among the five major racial and ethnic subgroups (Non-
Hispanic white, Non-Hispanic black, Asian Americans and Pacific Islanders, Native 
Americans and Native Alaskans, and Hispanic), rates were highest in non-Hispanic 




the highest incidence of and mortality rates from CRC and almost double the CRC 
mortality rate of other racial and ethnic minorities (Williams, Cubiella et al. 2016). From 
2009 through 2013, CRC incidence rates were 49 per 100,000 non-Hispanic blacks, 40 
per 100,000 non-Hispanic whites, and 32 per 100,000 Asian Americans and Pacific 
Islanders (Siegel, Miller et al. 2017). The magnitude of the disparity in mortality rates 
was much greater. Between 2010 and 2014, CRC death rates were 21 per 100,000 non-
Hispanic blacks, 15 per 100,000 non-Hispanic whites, and 10 per 100,000 Asian 
Americans and Pacific Islanders (Siegel, Miller et al. 2017). The higher rates for non-
Hispanic blacks can be explained by disproportionately low socioeconomic status, which 
is associated with a higher risk of CRC incidence and death (Doubeni, Laiyemo et al. 
2012, Grzywacz, Hussain et al. 2017). Low socioeconomic status can be defined based 
on several measures: the highest grade or level of schooling completed (less than high 
school diploma), job status (unemployed or in a managerial position), income below the 
federal poverty level, reliance on public assistance, lack of personal transportation, or 
income below $30,000 (Doubeni, Laiyemo et al. 2012). The official poverty measure was 
developed in the 1960s in conjunction with President Lyndon Johnson’s War on Poverty. 
Each September the U.S. Census Bureau releases an update on the national poverty rate 
based on data from the prior year (DeNavas-Walt, Proctor et al. 2014). The Census 
Bureau uses a set of money income thresholds that vary by family size and composition 
to determine the number of Americans living in poverty. The official poverty definition 
uses money income before taxes and does not include capital gains or noncash benefits 
such as public housing, Medicaid, and food stamps (Mitra and Brucker 2017). The 




Hispanic whites and 10% for Asians (Siegel, Miller et al. 2017). About 37% of the 
socioeconomic disparity in CRC incidence is attributable to a higher prevalence of 
behavioral risk factors, such as obesity, unhealthy dietary patterns, physical inactivity, 
and smoking (Doubeni, Major et al. 2012); while more than 40% of the racial disparity in 
CRC incidence can be explained by differences in screening uptake (Lansdorp-Vogelaar, 
Kuntz et al. 2012). The greater mortality disparity can be explained by inequities in 
comorbidities, access to care and treatment (Coughlin, Blumenthal et al. 2016), and 
deferred follow-up of screening-detected abnormalities (Laiyemo, Doubeni et al. 2010, 
Partin, Gravely et al. 2017). 
 
Table 2.1 Colorectal Cancer Incidence (2009-2013) and Mortality (2010-2014) Rates by 
Race, Ethnicity and Sex.  
 Incidence Mortality 
Overall 40.7 14.8 
 Men Women Men Women 
All persons 46.9 35.6 17.7 12.4 
Non-Hispanic white 46.1 35.2 17.3 12.3 
Non-Hispanic black 58.3 42.7 25.9 16.9 
Hispanic 42.8 29.8 15.0 9.2 
Asian Americans and Pacific Islanders 37.8 27.8 12.4 8.8 
Native Americans and Native Alaskans 51.4 41.2 19.5 14.0 





2.2 Colorectal Cancer Screening 
Most cases of CRC occur in average-risk adults. Increasing age, male sex, and 
non-Hispanic black race are associated with increased CRC incidence (Siegel, Miller et 
al. 2017). Early detection of CRC through routine screening has been demonstrated to be 
effective in reducing the incidence of and mortality from this disease (Whitlock, Lin et al. 
2008, Koretz 2016). The USPSTF strongly recommends screening for CRC beginning at 
the age of 50 and continuing until the age of 75 for individuals at average risk, indicating 
that there is high degree of certainty in the net benefit of screening for CRC (Whitlock, 
Lin et al. 2008, US Preventive Services Task Force 2016). Individuals who are at 
increased or high risk are generally recommended to receive colonoscopies and should 
begin receiving screenings earlier than the general population (Wong, Wong et al. 2015). 
The decision to screen for CRC in individuals aged 76 to 85 years should be an individual 
one, based on professional judgment and patient preference  (US Preventive Services 
Task Force 2016). In this document, we will focus on average-risk individuals: those who 
are asymptomatic and who have no personal or family history of colorectal cancer 
(Lieberman, Ladabaum et al. 2016). 
There are a number of screening tests available to detect early-stage CRC and 
prevent incident cases, including 1) flexible sigmoidoscopy every 5 years, 2) FIT-DNA 
every 1 or 3 years, 3) fecal occult blood test or fecal immunochemical testing every year, 
4) CT colonography every 5 years, 5) flexible sigmoidoscopy every 10 years plus FIT 
every year, and 6) and colonoscopy every 10 years (US Preventive Services Task Force 
2016). The USPSTF provided evidence that screening for CRC in adults aged 50 to 75 




of evidence to support their effectiveness, as well as distinct strengths and limitations (US 
Preventive Services Task Force 2016). When compared with no screening, all CRC 
screening strategies are cost-effective, though there is disagreement as to which screening 
strategy is the most cost-effective (Patel and Kilgore 2015). The screening tests listed 
above are not presented in any preferred or ranked order; instead, the purpose of 
recommending them is to maximize the total number of people who are screened, which 
will have the greatest effect on reducing CRC mortality (Ransohoff and Pignone 2013, 
US Preventive Services Task Force 2016). The USPSTF recommends screening via any 
of the accepted methods, as any method of screening is better than no screening at all (US 
Preventive Services Task Force 2016). 
 
Table 2.2 USPSTF Recommended Colorectal Cancer Screening Strategies 
Screening Method Screening Interval 
Stool-Based Tests 
   Guaiac-based fecal occult blood 
test (gFOBT) 
Every year 
   Fecal immunochemical test (FIT) Every year 
   FIT-DNA Every 1 or 3 years 
 
Direct Visualization/ Structural Exams 
   Colonoscopy Every 10 years 
   CT colonography Every 5 years 
   Flexible sigmoidoscopy Every 5 years 
   Flexible sigmoidoscopy with FIT 
Flexible sigmoidoscopy every 10 years plus 





The USPSTF derived several estimates from modeling conducted by the Cancer 
Intervention and Surveillance Modeling Network (CISNET) and presented the estimated 
number of life years gained, CRC deaths averted, lifetime colonoscopies required, and 
resulting complications per 1,000 screened adults aged 50 to 75 years for each of the 
screening strategies (Knudsen, Zauber et al. 2016, US Preventive Services Task Force 
2016). Across the different screening methods, colonoscopy showed the highest number 
of years gained and CRC deaths averted per 1,000 screened adults aged 50 to 75. On the 
other hand, colonoscopy had the highest lifetime colonoscopies required and the highest 
number of complications (gastrointestinal and cardiovascular events) of CRC screening 
and follow-up testing per 1,000 screened adults aged 50 to 75 (Knudsen, Zauber et al. 
2016, US Preventive Services Task Force 2016). Gastrointestinal events involve 
perforations, bleeding, transfusions, paralytic ileus, nausea and vomiting, dehydration, 
and abdominal pain (van Hees, Zauber et al. 2014, Knudsen, Zauber et al. 2016). 
Cardiovascular events include myocardial infarction, angina, arrhythmia, congestive 
heart failure, cardiac or respiratory arrest, syncope, hypotension, and shock (van Hees, 
Zauber et al. 2014, Knudsen, Zauber et al. 2016, US Preventive Services Task Force 
2016). A previous study has examined the differential harms of colonoscopy by age 
group and found increasing rates of serious adverse events from colonoscopy with 
increasing age (Lin, Piper et al. 2016).  
The benefits and risks of different screening options vary (Knudsen, Zauber et al. 
2016, US Preventive Services Task Force 2016), but from a clinical perspective, 




examine the entire length of the colon and remove all cancers and precancerous polyps 
during the same procedure (Levin, Lieberman et al. 2008, Rex, Johnson et al. 2009, Wolf, 
Basch et al. 2016, Benard, Barkun et al. 2018, Duarte, Bernardo et al. 2018). 
Colonoscopy is also recommended as a follow-up when another CRC screening is 
positive. Moreover, colonoscopy is validated in a randomized trial as having a mortality 
benefit (Patel and Kilgore 2015, Koretz 2016, US Preventive Services Task Force 2016).  
A colonoscopy remains the most commonly recommended test since it has the 
ability to detect polyps throughout the entire colon lumen (Wolf, Basch et al. 2016). It 
also has the advantage of not needing to be repeated for 10 years (US Preventive Services 
Task Force 2016). However, patients must meet several requirements before receiving a 
colonoscopy, such as bowel preparation, a facility visit, and a pre-procedure specialty 
office visit (Cheng, Huang et al. 2017). An adequate bowel preparation is needed in order 
for the doctors to view the colon clearly. Inadequate bowl preparation has been shown to 
decrease the adenoma detection rate (Sherer, Imler et al. 2012, Brimhall, Hankins et al. 
2016). It requires taking medication that causes diarrhea to empty the colon (Cheng, 
Huang et al. 2017). Furthermore, sedation is designed to depress an individual’s level of 
consciousness and to provide anxiolysis, amnesia, and analgesia. Therefore, colonoscopy 
requiring a day away from work and a chaperone to provide transportation (Wolf, 
Fontham et al. 2018). Polyps can be removed by passing a wire loop through the 
colonoscope either to cut the polyp from the wall of the colon, or demolish it in place 
using an electric current (Levin, Lieberman et al. 2008). Use of flexible sigmoidoscopy 
and fecal occult blood test have considerably declined in the past two decades in favor of 




al. 2009, Klabunde, Cronin et al. 2011), a fact which may be partly attributed to growing 
reimbursement for average-risk colonoscopies, physician preferences and referral 
patterns (Harewood and Lieberman 2004, Ransohoff 2005, Duarte, Bernardo et al. 2018). 
In 2012, 62% of all adults aged 50 to 75 who were screened for CRC received a 
colonoscopy versus other modalities, with fecal occult blood test coming in second at 
10% (Centers for Disease Control and Prevention 2013). However, colonoscopies miss 
around 10% of significant lesions in expert setting and are more costly on a one-time 
basis than any other screening test (Meester, Doubeni et al. 2015). In addition, many 
individuals do not want an invasive test or a test that requires bowel preparation 
(Inadomi, Vijan et al. 2012, Cheng, Huang et al. 2017). Moreover, colonoscopies involve 
a wider variation in quality and higher potential for patient injury than any other 
screening test (Rembacken, Hassan et al. 2012, Pinto-Pais 2017, Rex and Ponugoti 2017). 
Finally, access may be limited by insurance status and local resources (Joseph, Meester et 
al. 2016). Therefore, providers should consider patient preference and test availability 
when making CRC screening recommendations and offering choices. Shared decision 
making can also improve adherence (Inadomi, Vijan et al. 2012, Wolf, Fontham et al. 
2018). 
Flexible sigmoidoscopy is an endoscopic procedure that examines the lower half 
of the colorectal lumen. A simple bowel preparation is needed before the examination 
(Wolf, Fontham et al. 2018). If a pre-cancerous adenoma or colorectal cancer is found, a 
follow-up colonoscopy will be required to examine the entire colon (Niedermaier, Weigl 
et al. 2018). Flexible sigmoidoscopy is usually performed without sedation, thus 




RCTs have demonstrated that a single flexible sigmoidoscopy is a safe, well accepted, 
and effective screening method for the prevention of CRC (Atkin, Edwards et al. 2010, 
Segnan, Armaroli et al. 2011, Holme, Loberg et al. 2014, Atkin, Wooldrage et al. 2017). 
A recent 17-year follow-up of the UK Flexible Sigmoidoscopy Screening Trial reported a 
26% reduction in the incidence of CRC and a 30% reduction in mortality (Atkin, 
Wooldrage et al. 2017).  
CT colonography has been recommended by the American Cancer Society since 
2008 and was added to the USPSTF guideline in 2016 (US Preventive Services Task 
Force 2016, Wolf, Fontham et al. 2018). CT colonography involves the acquisition of 
thin-slice computed tomography images that can be evaluated as two-dimensional images 
or reconstructed into three-dimensional images of the colorectal lumen (Wolf, Fontham et 
al. 2018). Bowel preparation is needed before the examination and follow-up 
colonoscopy is required to remove any abnormalities detected (Wolf, Fontham et al. 
2018). According to a systematic review and meta-analysis study conducted by Lin and 
colleagues (2012), patients preferred CT colonography over colonoscopy. Limited bowel 
preparations for CT colonography may be the reason for this preference (Lin, Kozarek et 
al. 2012). Several studies reported that CRC detection rates with CT colonography were 
essentially identical to those achieved with colonoscopy (Pickhardt, Choi et al. 2003, 
Johnson, Chen et al. 2008). However, a systematic review of detection rates for advanced 
colorectal neoplasia (ACN) among asymptomatic patients showed that 6% of patients 
who received a CT colonography were diagnosed with cancer, while 9% who received a 
colonoscopy were diagnosed with cancer (Duarte, Bernardo et al. 2018). Duarte and 




asymptomatic patients, but because CT colonography is inferior in detecting ACN, it 
should not replace colonoscopy (Duarte, Bernardo et al. 2018).   
Stool-based tests examine the stool for secondary signs of cancer such as bleeding 
or shedding of cells and are less invasive and less expensive than other options 
(Lieberman, Ladabaum et al. 2016). Stool-based tests do not require a bowel preparation. 
They can be completed in the privacy of the patient’s home and do not require time off 
from work (Wolf, Fontham et al. 2018). However, Modeling studies suggest that the 
number of years of life saved through a high-quality stool-based screening strategy are 
similar to the outcomes of a high-quality colonoscopy screening strategy (Knudsen, 
Zauber et al. 2016, US Preventive Services Task Force 2016). The fecal occult blood test 
averted 22 CRC deaths per 1,000 screened adults aged 50 to 75, and the fecal 
immunochemical test averted 22 CRC deaths per 1,000 screened adults aged 50 to 75. 
During the same time period, Colonoscopy averted 24 CRC deaths per 1,000 screened 
adults aged 50 to 75 (Knudsen, Zauber et al. 2016, US Preventive Services Task Force 
2016). All positive stool-based tests must be followed up with colonoscopy (Partin, 
Gravely et al. 2017, May, Yano et al. 2018).  
FIT-DNA is a new test with limited data on screening outcomes (Lieberman, 
Ladabaum et al. 2016). FIT-DNA combines tests for stool DNA markers associated with 
cancer and adenomas with a FIT with published performance characteristics (Wolf, 
Fontham et al. 2018). This test can be done in the privacy of the patient’s home and does 
not require time off work (Wolf, Fontham et al. 2018). Only one such test (called 
Cologuard) is currently available in the United States. It was approved by the U.S. Food 




who have an average risk of CRC. Effective October 9, 2014, Medicare covered the stool 
DNA test with no co-insurance or Part B deductible for Medicare beneficiaries who are 
aged 50 to 85 and who have no symptoms of CRC or are at increased risk of CRC. FIT-
DNA testing is covered by Medicare at three-year intervals, as it is considered an 
acceptable testing modality by USPSTF (US Preventive Services Task Force 2016). 
According to a large, manufacturer-funded, multicenter, comparative trial of DNA and 
FIT testing in average-risk individuals, the sensitivity of DNA testing for detecting 
colorectal cancer was 92%, and the sensitivity of FIT was 74%. The sensitivity for 
detecting advanced precancerous lesions was 42% with DNA testing and 24% with FIT. 
Moreover, specificities with DNA testing and FIT were 87% and 95%, respectively 
(Imperiale, Ransohoff et al. 2014). FIT-DNA is included in the American Cancer Society 
and USPSTF guidelines (US Preventive Services Task Force 2016, Wolf, Fontham et al. 
2018). All positive tests must be evaluated by colonoscopy (Wolf, Fontham et al. 2018). 
The mortality rate from CRC has been decreasing steadily since 1980 (Weir, 
Thompson et al. 2015, Siegel, Miller et al. 2017), a fact which partially may be 
attributable to removal of pre-cancerous, adenomatous polyps at an early stage based on 
diagnosis of CRC and widespread use of colonoscopy or other screening approaches 
(Cunningham, Atkin et al. 2010, Edwards, Ward et al. 2010, Lieberman 2010, Martin, 
Tully et al. 2017, Partin, Gravely et al. 2017). Nonetheless, self-reported CRC screening 
rates from the National Health Interview Survey are at 58%, and the National Committee 
for Quality Assurance (NCQA) indicates that only 60% of commercial and 69% of 
Medicare plan members aged 50 to 75 years received an appropriate CRC screening in 




indicate that around 65% of adults aged 50 to 75 years reported having had one of the 
colorectal screening tests recommended by USPSTF, and around 60% of adults aged 50 
to 75 years had received a colonoscopy within the past 10 years (Joseph, King et al. 2012, 
Liss and Baker 2014).  
 
Table 2.3 Percentage of adults who received colorectal cancer screenings according to the 
recommended schedule, by selected sociodemographic characteristics and health care 
access – National Health Interview Survey, United States, 2015 
Characteristics N % 
Overall 12,650 62.4 
Age group (years)   
     50-64 7,947 57.9 
     65-75 4,703 71.8 
Race   
     White 10,051 63.7 
     Black 1,777 59.3 
     American Indian/Alaska Native 160 48.4 
     Asian 595 52.1 
Ethnicity   
     Non-Hispanic 11,163 64.2 
     Hispanic 1,487 47.4 
Education   
     Less than high school 1,681 46.7 
     High school graduate/GED 3,275 58.2 
     Some college/Associate degree 3,896 63.5 
     College graduate 3,754 70.7 
Percentage of federal poverty threshold   
     <139 2,702 46.9 
     139-250 2,432 56.1 
     250-400 2,455 62.6 
     >400 5,060 70.0 
Health care coverage   
     Private 7,628 65.6 
     Military 702 77.6 
     Public only 3,494 60.1 
     Uninsured 790 25.1 
Note: Results for individuals aged 50-75 years who received a fecal occult blood test 
within 1 year, a sigmoidoscopy within 5 years and fecal occult blood test within 3 years, 




In 2010, the US Department of Health and Human Services (HHS) initiated 
HP2020, which covered several objectives for reducing cancer mortality. Each objective 
was assigned a baseline measure in 2007 and a target to be achieved by 2020. HP2020 
calls for a 15% reduction in death rates from 2007 to 2020 for CRC (Weir, Thompson et 
al. 2015). Moreover, the National Colorectal Cancer Roundtable (NCCRT) initiated a 
goal to increase the CRC screening rate to 80% in the eligible population by 2018 
(Karlitz, Oliphant et al. 2017). Achieving this goal would avert 280,000 new cases of 
CRC and 200,000 deaths from the disease by 2030, and 24.4 million people would be 
screened (Fedewa, Ma et al. 2015, Meester, Doubeni et al. 2015). Nonetheless, the 
aforementioned screening rates are lower than the use of preventive interventions for 
other screening-amenable cancers, below the 80% coverage of the CRC screening target, 
and below the HP2020 target of 71% (Swan, Breen et al. 2010, Karlitz, Oliphant et al. 
2017, White, Thompson et al. 2017). 
Previous studies have identified numerous barriers facing individuals who wish to 
receive CRC screenings, including barriers at the patient, provider, and health care 
system levels (McLachlan, Clements et al. 2012, Ramdass, Petraro et al. 2014, Bromley, 
May et al. 2015, Wang, Qiu et al. 2018).  
These barriers include low educational attainment and literacy, gender (female), 
race (Hispanic or non-Hispanic black), embarrassment or fear concerning the procedure, 
concerns about the cost, comorbidities, and lack of health insurance (Meissner, Klabunde 
et al. 2012, Weiss, Smith et al. 2013, Hughes, Watanabe-Galloway et al. 2015, Knight, 
Kanotra et al. 2015, Zhao, Okoro et al. 2018). Meanwhile, having a higher income, being 




source of care, and having an increased perceived risk of CRC are associated with 
increased CRC screening rates (Palmer, Midgette et al. 2010, James, Daley et al. 2011, 
Winterich, Quandt et al. 2011, Meissner, Klabunde et al. 2012, Wilkins, Gillies et al. 
2012, Ruggieri, Bass et al. 2013, Ramdass, Petraro et al. 2014). Racial and ethnic 
disparities in CRC screening have been documented broadly; and most studies indicate a 
lower rate of screening among racial and ethnic minorities (Shih, Zhao et al. 2006, 
Burnett-Hartman, Mehta et al. 2016, Hong, Tauscher et al. 2017). Hong and colleagues 
(2017) also reported racial and ethnic disparities in CRC screening among Hispanics and 
Asian Americans (Hong, Tauscher et al. 2017). The Centers for Disease Control and 
Prevention (CDC) reported that racial and ethnic minorities were significantly less likely 
to receive colonoscopies within the recommended 10-year guidelines than non-Hispanic 
whites (Centers for Disease Control and Prevention 2013).   
Being at the upper end of the age-range screening guidelines was associated with 
higher rates of CRC screening (Seeff, Nadel et al. 2004, Ellison, Jandorf et al. 2011, 
Centers for Disease Control and Prevention 2013, Ramdass, Petraro et al. 2014, White, 
Thompson et al. 2017). White and colleagues (2017) reported that individuals aged 65 to 
75 years were significantly more likely to receive CRC screening than individuals aged 
50 to 64 years (White, Thompson et al. 2017). Ellison and colleagues (2011) found that 
individuals aged 65 years or older were 2.17 times more likely to be receive CRC 
screening than individuals aged 50 to 64 years (Ellison, Jandorf et al. 2011). Ramdass 
and colleagues (2014) found that individuals aged 61 to 70 years and 71 to 80 years were 
significantly more likely to have received a screening colonoscopy in the past 10 years 




reported that individuals aged 65 to 75 years were significantly more likely to have 
received a colonoscopy within the past 10 years than individuals aged 50 to 64 years 
(Centers for Disease Control and Prevention 2013). Seeff and colleagues (2004) found 
that individuals aged 60 to 69 were 1.87 times more likely to have received an endoscopy 
within the past 10 years than individuals aged 50 to 59 years, and individuals aged 70 
to79 years were 2.12 times more likely to have received an endoscopy than those aged 50 
to 59 years (Seeff, Nadel et al. 2004).  
Marital status was associated with higher rates of CRC screening (Seeff, Nadel et 
al. 2004, Ellison, Jandorf et al. 2011, Grzywacz, Hussain et al. 2017). Ellison and 
colleagues (2011) found that married participants were 2.09 times more likely to receive 
CRC screenings than unmarried participants (Ellison, Jandorf et al. 2011). Wilcox and 
colleagues found that single participants were 0.65 times less likely to have a 
colonoscopy than other participants (Wilcox, Acuna et al. 2015). Seeff and colleagues 
(2004) found that unmarried participants were 0.86 times less likely to have received an 
endoscopy within the past 10 years than married participants (Seeff, Nadel et al. 2004).  
There are also gender differences in CRC screening rates (Seeff, Nadel et al. 
2004, Partin, Gravely et al. 2016). Men are significantly more likely to visit endoscopy 
clinics than women. Partine and colleagues (2016) found that women are less likely to 
have had an colonoscopy screening than men (Partin, Gravely et al. 2016). Ramdass and 
colleagues (2014) found that men were 2.71 times more likely than women to have had a 
screening colonoscopy in the past 10 years (Ramdass, Petraro et al. 2014). Seeff and 
colleagues (2004) found that women were 0.58 times less likely than men to have 




Individuals with lower household incomes and less education are less likely to 
have had a CRC screening (Courtney, Paul et al. 2013, Fedewa, Ma et al. 2015, Meyer, 
Allard et al. 2016, White, Thompson et al. 2017). Previous studies found a strong 
association between colonoscopy use and income, with higher income groups being 
associated with higher rates of colonoscopy use (Benarroch-Gampel, Sheffield et al. 
2012, Centers for Disease Control and Prevention 2013, Solbak, Xu et al. 2018). 
Grzywach and colleagues (2017) found that individuals with lower income levels were 
less likely to have a sigmoidoscopy or colonoscopy than individuals with higher income 
levels (Grzywacz, Hussain et al. 2017).  
Health insurance coverage is associated with CRC screening. Zhao and colleagues 
(2018) found that compared with persons who are adequately insured, those who are 
underinsured who were uninsured are less likely to receive CRC screening (Zhao, Okoro 
et al. 2018). White and colleague (2017) found that persons having any type of health 
insurance were more likely to receive CRC screening than those who had no insurance at 
all (White, Thompson et al. 2017). Individuals having health insurance were more likely 
to have received a colonoscopy within the past 10 years than those who had no health 
insurance (Centers for Disease Control and Prevention 2013). Individuals having private 
health insurance were 1.84 times more likely to receive colonoscopy screening than those 
without private health insurance (Courtney, Paul et al. 2013).  
Residence location is associated with CRC screening (Meyer, Allard et al. 2016, 
Partin, Gravely et al. 2016, Wang, Qiu et al. 2018). People who live in rural or suburban 
settings are significantly less likely to receive CRC screening than people who live in city 




screenings than urban residents (Meyer, Allard et al. 2016). Partin and colleagues (2016) 
showed that people who live in urban areas were 1.13 times more likely to miss 
colonoscopy than people who live in rural or highly rural areas (Partin, Gravely et al. 
2016). Shih and colleague (2006) reported that people who live in the West were 1.24 
times more like to have CRC screenings than people who live in the Northeast (Shih, 
Zhao et al. 2006).     
Healthy lifestyles, including having other screening tests, exercising, eating large 
amounts of fruits and vegetables, and not smoking, were associated with higher rates of 
CRC screening (Seeff, Nadel et al. 2004, Sewitch, Fournier et al. 2007, Ellison, Jandorf 
et al. 2011, Grzywacz, Hussain et al. 2017). Ellison and colleagues (2011) found that 
individuals who had regular mammograms were 2.38 times more likely to receive CRC 
screening than those who did not (Ellison, Jandorf et al. 2011). Sewitch and colleagues 
(2007) found that individuals who received regular flu shots were 1.51 times more likely 
to receive endoscopies than those who did not (Sewitch, Fournier et al. 2007).  
There was extensive evidence to support the impact of primary prevention 
strategies, primarily through lifestyle modification (Tarraga Lopez, Albero et al. 2014). 
Previous studies have indicated that avoidance of smoking and alcohol consumption, 
maintaining a healthy weight, and moderate physical activity are associated with 
markedly lower risks of CRC (Chan and Giovannucci 2010, Gong, Hutter et al. 2012, 
Crosara Teixeira, Braghiroli et al. 2014, Gong, Hutter et al. 2016). To achieve a 
significant reduction in CRC incidence, primary prevention is crucial complement to 
CRC screening. Smokers have an increased risk of receiving a diagnosis of an adenoma 




al. 2012, Tarraga Lopez, Albero et al. 2014). Previous studies found that individuals who 
engaged in any amount of vigorous activity were at lower risk of developing CRC than 
those who did not engage in this activity and regular physical activity cuts the risk of 
CRC by round 40% (Tarraga Lopez, Albero et al. 2014, Nunez, Nair-Shalliker et al. 
2018). 
These healthy lifestyles were also associated with higher rates of CRC screening 
(Seeff, Nadel et al. 2004, Sewitch, Fournier et al. 2007, Ellison, Jandorf et al. 2011, 
Grzywacz, Hussain et al. 2017). Individuals with moderate physical activity were 1.25 
times more likely to have received an endoscopy within the past 10 years than those who 
had no significant physical activity (Seeff, Nadel et al. 2004). In addition, people who 
had exercised within the past 30 days were 1.25 times more likely to have had a 
sigmoidoscopy or colonoscopy than those who did not exercise (Grzywacz, Hussain et al. 
2017).  
With regard to healthy lifestyle habits, smoking status deserves particular 
attention. Sewitch and colleagues (2007) found that former smokers were 1.20 times 
more likely, and those who had never smoked were 0.84 times less likely to have 
received an endoscopy in the past 10 years than current smokers (Sewitch, Fournier et al. 
2007). On the other hand, Seeff and colleagues (2004) found that current smokers were 
0.82 times less likely to have received an endoscopy within the past 10 years than those 
who had never smoked. Meanwhile, Grzywach and colleagues (2017) found that current 
smokers were more likely to have had a sigmoidoscopy or colonoscopy than those who 




The absence or presence of comorbidities is associated with CRC screening 
(Grzywacz, Hussain et al. 2017, Wang, Qiu et al. 2018). Grzywach and colleagues (2017) 
found that individuals with diabetes were 1.45 times more likely to have a sigmoidoscopy 
or colonoscopy than those without diabetes, and individuals with an activity limitation 
were 1.33 times more likely to have a sigmoidoscopy or colonoscopy than those with no 
limitation (Grzywacz, Hussain et al. 2017). Partin and colleagues (2017) found that 
individuals with low Charlson comorbidity scores were more likely to have 
colonoscopies than those with higher scores. More specifically, individuals with zero 
Charlson scores were 1.23 times more likely to have colonoscopies than individuals with 
Charlson scores ≥ 3 (Partin, Gravely et al. 2017). Wang and colleagues (2018) discovered 
that people who had chronic conditions were more likely to be up-to-date on CRC 
screenings than those who did not have chronic conditions (Wang, Qiu et al. 2018).  
Moreover, a perceived low or moderate CRC risk significantly increased a person’s odds 
of being screened by colonoscopy when compared to those who had no unusual risk for 
CRC (Ramdass, Petraro et al. 2014). López-Charneco and colleagues (2013) found that 
individuals with perceived fair to poor health status were 1.17 times more likely to 
receive a sigmoidoscopy or colonoscopy within 5 years than individuals with perceived 
good to excellent health status (Lopez-Charneco, Perez et al. 2013).    
Provider-level barriers to CRC screening included physician’s gender, specialty, 
years in practice, lack of provider recommendation, lack of provider recognition of 
barriers, and lack of a regular provider (Holt, Shipp et al. 2009, James, Daley et al. 2011, 
Ruggieri, Bass et al. 2013, Ramdass, Petraro et al. 2014, Peterson, Ostroff et al. 2016). 




recommendation (Ramdass, Petraro et al. 2014, Peterson, Ostroff et al. 2016). A 
systematic review showed that provider recommendation significantly improves 
screening rates (Peterson, Ostroff et al. 2016). Furthermore, it has been found that 
offering patients a choice of CRC screening through shared decision making, rather than 
recommending a single test, can improve adherence to screening (Inadomi, Vijan et al. 
2012, Wolf, Fontham et al. 2018). Ramdass and colleagues (2014) found that provider 
recommendation for a colonoscopy is the most effective strategy in promoting screening 
colonoscopies in the US (Ramdass, Petraro et al. 2014). In order for their screening 
recommendations to be figured into the NCCRT target rate of 80% and the HP2020 target 
of 71%, providers must recommend CRC screenings to all eligible individuals and 
provide follow-up to ensure their recommendations are followed. This is easier in some 
practice settings than others; for instance, large integrated health systems have systems in 
place to remind physicians and provide follow-up for recommendations (Potter, Ackerson 
et al. 2013). Thus system-level interventions could promote achieving the target 80% 
coverage of CRC screening and the HP2020 target of 71%. Moreover, outreach strategies 
whereby patients receive invitations to CRC screening via mail have demonstrated an 
increase in CRC adherence rates (Kempe, Shetterly et al. 2012, Gupta, Halm et al. 2013, 
Singal, Gupta et al. 2016).  
Individuals having a regular physician or usual source of care were significantly 
more likely to receive CRC screening than those who did not (Ellison, Jandorf et al. 
2011, Centers for Disease Control and Prevention 2013, Grzywacz, Hussain et al. 2017, 
White, Thompson et al. 2017). White and colleagues (2017) found that individuals 




individuals who did not (White, Thompson et al. 2017). Ellison and colleagues (2011) 
found that individuals having a regular physician were significantly more likely to be 
CRC screening-adherent (Ellison, Jandorf et al. 2011). Grzywach and colleagues (2017) 
found that individuals having a personal doctor and health care provider were more likely 
to have a sigmoidoscopy or colonoscopy than those who did not (Grzywacz, Hussain et 
al. 2017). Seeff and colleagues (2004) found that individuals having a usual source of 
care were 1.77 times more likely to have received an endoscopy within the past 10 years 
than those who did not (Seeff, Nadel et al. 2004). The CDC reported that individuals 
having a regular provider were significantly more likely to have received a colonoscopy 
within the past 10 years than individuals who did not (Centers for Disease Control and 
Prevention 2013).  
A few studies have found that female patients have a preference for female 
gastroenterologists for office visits and colonoscopies (Menees, Inadomi et al. 2005, 
Shah, Karasek et al. 2011, Chong 2012). The main reason for this sex preference was 
embarrassment, and a higher level of education was a significant factor in producing 
higher levels of patient embarrassment. Shah and colleagues (2011) confirmed that more 
than 30% of female patients would avoid receiving a colonoscopy if they were unable to 
have a physician of their sex preference (Shah, Karasek et al. 2011). Menees and 
colleagues (2011) also confirmed that 43% of female patients expressed preference for 
female colonoscopists; and of these, 87% would be willing to wait more than 30 days in 
order to access a female colonoscopist (Menees, Inadomi et al. 2005). Therefore, 





System-level barriers to CRC screening included the out-of-pocket cost, capacity, 
high numbers of uninsured, fewer specialist referrals, fewer interactions with a primary 
care physician (Palmer, Midgette et al. 2008, Holt, Shipp et al. 2009, Hatcher, Dignan et 
al. 2011, Lukin, Jandorf et al. 2012, Wilkins, Gillies et al. 2012, Joseph, Meester et al. 
2016). A recent study reported that the estimated colonoscopy capacity was sufficient to 
screen 80% of the eligible U.S. population (Joseph, Meester et al. 2016). However, 
colonoscopies vary by quality, and high-quality colonoscopies take considerably more 
time than the average time physicians spend on colonoscopies (Vicari 2010, Keswani, 
Yadlapati et al. 2015, Bitar, Zia et al. 2018). Previous studies have demonstrated that 
physician supply has been associated with increased use of colonoscopy (Brouse, Wolf et 
al. 2008, Haas, Brawarsky et al. 2010, Benarroch-Gampel, Sheffield et al. 2012, Eberth, 
Josey et al. 2017). Benarroch-Gampel and colleagues (2012) examined the influence of 
colonoscopist and primary care physician supply on racial disparities in receipt of 
colonoscopy and found that while increasing colonoscopist and primary care physician 
capacity was associated with increased colonoscopy use in whites, but it was associated 
with decrease in colonoscopy use in blacks and Hispanics (Benarroch-Gampel, Sheffield 
et al. 2012). An increased supply of providers may have little beneficial effect on race 
and ethnic disparities in the receipt of colonoscopies or on geographic disparities in the 
receipt of colonoscopies (Benarroch-Gampel, Sheffield et al. 2012, Eberth, Josey et al. 
2017). Interventions should focus on improving screening in populations living in rural 
areas and among minorities. If gastroenterologists are in short supply, alternatives may be 
considered in the short-run like training primary care providers to conduct colonoscopies 




Out-of-pocket costs may dampen patients’ willingness to undergo CRC screening; 
and this is especially true for colonoscopies, which usually involve relatively high-cost 
sharing (Klabunde, Riley et al. 2004, Hamman and Kapinos 2015). In some areas, 
however, charges for the same services can differ more than tenfold, varying from 
roughly $500 to more than $8,000 (Lieberman and Allen 2015, Robinson, Brown et al. 
2015). Pyenson and colleagues (2014) determined the costs related with colonoscopy in 
the commercial and Medicare populations and confirmed that the average allowed 
amount for a screening colonoscopy was $2,146 in the commercial population and $1,071 
in the Medicare population, with average cost sharing of $334 the commercial population 
and $275 in the Medicare population (Pyenson, Scammell et al. 2014). Previous studies 
have shown that cost-sharing reduces preventative health care use, including the use of 
highly effective screening tests (Busch, Barry et al. 2006, Goodwin and Anderson 2012). 
One study examined the impact of eliminating coinsurance for colonoscopy and found 
that waiving coinsurance for colonoscopies resulted in an 18% increase in screening 
(Khatami, Xuan et al. 2012). 
Beginning in September 2010, the ACA required all non-grandfathered private 
health plans to offer coverage of CRC screenings without cost-sharing to address the 
negative consequences of financial barriers on the use of preventative services and to 
promote CRC screening. Consistent with the ACA policy requirement, beginning January 
1, 2011, Medicare waived Part B deductibles for all colonoscopies and eliminated 
coinsurance for screening colonoscopies, though not for therapeutic ones (Howard, Guy 
et al. 2014, Hamman and Kapinos 2015). Therefore, Medicare beneficiaries may face 




colonoscopy, in which case patients are billed a copay if diagnostic colonoscopy. 
Medicare beneficiaries are also responsible for Part B deductible and coinsurance when a 
colonoscopy is performed as part of a two-step screening process after another CRC 
screening is positive (Howard, Guy et al. 2014). This loophole may discourage the use of 
screening, so eliminating remaining loopholes for Medicare beneficiaries could improve 
screening rates.  
The Removing Barriers to Colorectal Cancer Screening Act of 2017 (H.R. 
1017/S. 479), sponsored by US Representatives Charlie Dent and Donald Payne, Jr., in 
the House of Representatives and Senator Sherrod Brown in the Senate, works to correct 
an oversight in current law that requires Medicare beneficiaries to cover the cost of their 
copayment for a free screening colonoscopy if a polyp is discovered and removed during 
the procedure (Howard, Guy et al. 2014, Hamman and Kapinos 2015). Under current law, 
Medicare waives coinsurance and deductibles for colonoscopies. However, when a polyp 
is discovered and removed, the procedure is reclassified as therapeutic for Medicare 
billing purposes and beneficiaries become responsible for paying 20% coinsurance 
(Hamman and Kapinos 2015). This bill would eliminate costs for Medicare beneficiaries 
when a polyp is discovered and removed, ensuring that unexpected copays do not deter a 
patient from receiving screening (Howard, Guy et al. 2014). By eliminating financial 
barriers, this legislation would attain higher screening rates and reduce the incidence of 






2.3 Medicare Coverage of Colorectal Cancer Screening 
Medicare is the federal health insurance program for people who are 65 or older 
(Altman and Frist 2015, Huffman and Upchurch 2018). It also covers younger adults with 
permanent disabilities and End-Stage Renal Disease. Medicare Part A (Hospital 
Insurance) covers inpatient hospital stays, care in a skilled nursing facility, hospice care, 
and some home care. Medicare Part B (Medical Insurance) covers doctor’s services, 
outpatient care, medical supplies, and preventive services. Medicare Part C (Medicare 
Advantage Plans) is a type of Medicare health plan offered by a private company that 
contracts with Medicare. Medicare Part C provides all the benefits of Part A and Part B. 
Medicare Part D provides prescription drug coverage (Altman and Frist 2015).  
Medicaid is a joint federal and state health insurance program providing need-
based insurance to low-income children and adults, and many people are eligible for both 
Medicare and Medicaid. Roughly 10 million individuals are “dual eligible” for Medicare 
and Medicaid (Altman and Frist 2015).     
Medicare is the largest payer for health care services in the United States and 
covers many preventive services, including colorectal cancer screening (Altman and Frist 
2015). Today, Medicare Part B covers several types of CRC screening tests, including 
barium enema, colonoscopy, fecal occult blood test, multi-target stool DNA test, and 
flexible sigmoidoscopy (Howard, Guy et al. 2014). The Centers for Medicare and 
Medicaid Services (CMS) pays 100% of the charge for fecal occult blood tests, flexible 
sigmoidoscopies, colonoscopies, and multi-target stool DNA tests and 80% of the charge 




services were excluded (Lesser, Krist et al. 2011). At the time, there was no strong 
evidence presented from a randomized controlled trial to show that CRC screening was 
effective in reducing CRC incidence and mortality. Therefore, CRC screening was not 
reimbursed or widely practiced. However, after three RCTs in the mid-1990s suggested 
efficacy, a wide consensus developed.  
The USPSTF made a decision to endorse CRC screening in 1996 and Medicare 
made a decision to reimburse for its use in 1998 (Ransohoff 2005). In 1998, Medicare 
provided for coverage of colorectal cancer screening procedures under Medicare Part B. 
Medicare covered (1) annual fecal occult blood tests (FOBTs); (2) flexible 
sigmoidoscopy over 4 years; (3) screening colonoscopy every 10 years for persons at 
average risk for colorectal cancer, or every two years for persons at high risk for 
colorectal cancer; (4) barium enema every 4 years as an alternative to flexible 
sigmoidoscopy, or every 2 years as an alternative to colonoscopy for persons at high risk 
for colorectal cancer; and (5) other procedures the Secretary finds appropriate based on 
consultation with appropriate experts and organizations. Effective January 1, 2004, 
Medicare extended the FOBT screening definition to provide for either one guaiac-based 
FOBT (gFOBT) or one immunoassay-based FOBT (iFOBT) at a frequency of every 12 
months. Prior studies found that CRC screening rates increased after the Medicare 
coverage expansions, but screening rates remained below the recommended levels (Ko, 
Kreuter et al. 2005, O'Malley, Forrest et al. 2005, Gross, Andersen et al. 2006, Shih, 
Zhao et al. 2006, Ananthakrishnan, Schellhase et al. 2007, Fenton, Tancredi et al. 2009, 
White, Vernon et al. 2011). The persistently low screening rates, even after 




might not be an important barrier to CRC screening, and that they should advocate for 
new approaches (Stimpson, Pagan et al. 2012). However, these expansions in coverage 
left gaps; Medicare beneficiaries without supplemental insurance were responsible for up 
to 20% of the allowable charges, which may be the reason for the continued underuse of 
CRC screening.   
On January 1, 2005, Medicare started covering a one-time initial preventive visit, 
known as the ‘‘Welcome to Medicare’’ visit (WMV). The preventive services were made 
available to new beneficiaries within six months of beginning their Part B coverage 
(Salloum, Jensen et al. 2013). The WMV provides an opportunity to review Medicare 
beneficiaries’ medical history, current health status, and risk factors, as well as to provide 
education, counseling, and referrals (Misra, Lloyd et al. 2018). Medicare’s regular cost-
sharing provisions apply to the visit; that is, it is subject to the Medicare annual Part B 
deductible ($100) and a standard 20% Medicare copay above that amount. In 2008, 
Medicare waived its Part B deductible for colorectal cancer screening, and the screening 
was made available to new beneficiaries within 12 months of beginning their Part B 
coverage. However, until 2011, a beneficiary was still responsible for standard 20% 
Medicare copays (Salloum, Jensen et al. 2013). As a result of the ACA, Medicare waived 
its copays for the WMV, making this benefit free starting in 2011. Historically, only 3 – 
6% of eligible beneficiaries get a WMV, even after changes extending benefit eligibility 
and waiving the annual deductible (Cuenca 2012, Ganguli, Souza et al. 2017). Recently, 
Misra and colleagues (2018) examined the impact of the ACA on WMV utilization and 
found that annual WMV rates began at 1% in 2005 and increased to 12% in 2016. The 




utilization of WMV among newly enrolled Medicare beneficiaries (Misra, Lloyd et al. 
2018).   
In 2011, Medicare introduced the annual wellness visit (AWV) to provide an 
annual preventive health benefit to all Medicare beneficiaries who have been enrolled in 
Medicare Part B for at least 12 months. The AWV is free for beneficiaries and provides a 
regular opportunity to review each beneficiary’s medical history, risk factors, and 
functional abilities (Ganguli, Souza et al. 2017). Based on current health status and risk 
factors, clinicians develop an individualized prevention plan that establishes preventive 
screenings and interventions, including colorectal cancer screening (Colburn and 
Nothelle 2018). Shen and colleagues (2017) reported that AWV utilization has increased 
over time, from 8% in 2011 to 20% in 2015 (Shen, Warnock et al. 2017).  
The ACA required all non-grandfathered private health plans to offer coverage of 
CRC screenings without cost-sharing to address the negative consequences of financial 
barriers on the use of preventative services and to promote CRC screening. Consistent 
with the ACA policy requirement, beginning January 1, 2011, Medicare waived Part B 
deductibles and coinsurance for Medicare-approved CRC screenings. Moreover, 
Medicare waived Part B deductibles for all colonoscopies and eliminated coinsurance for 
screening colonoscopies, though not for therapeutic ones (Howard, Guy et al. 2014, 
Hamman and Kapinos 2015). Therefore, Medicare beneficiaries may face unexpected 
out-of-pocket liabilities when a polyp is detected and removed during a colonoscopy, in 
which case patients are billed a copay. Medicare beneficiaries are also responsible for 
Part B deductible and coinsurance when a colonoscopy is performed as part of a two-step 




This loophole may discourage the use of screening, so eliminating remaining loopholes 
for Medicare beneficiaries could improve screening rates. 
 
 
Table 2.4 Key Medicare Policy Changes for Colorectal Cancer Screening 
 
Year Policy Who Payment 
1998 (1) annual FOBT; (2) flexible 
sigmoidoscopy over 4 years; (3) 
screening colonoscopy for individuals at 
average risk every 10 years, or for 
individuals at high risk every 2 years; (4) 
barium enema every 4 years  
Part B 20% copay 
2004 Extended annual immunoassay-based 
(iFOBT)  
Part B 20% copay 
2005 Welcome to Medicare: one-time initial 
preventive visit 
New beneficiaries 




2008 Extended Welcome to Medicare New beneficiaries 
within 12 months 
20% copay 
2011 Extended Welcome to Medicare New beneficiaries 
within 12 months 
Free 
2011 Annual Wellness Visit Part B for at least 
12 months 
Free 
2011 (1) annual FOBTs; (2) flexible 
sigmoidoscopy over 4 years; (3) 
screening colonoscopy for individuals at 
average risk every 10 years, or for 
individuals at high risk every 2 years; (4) 
barium enema every 4 years as an 
alternative to flexible sigmoidoscopy, or 
every 2 years for individuals at high risk;  






2014 Extended Multi-target stool DNA test 
for individuals at average risk every 3 
years 






FIT-DNA is a new test and combines tests for stool DNA markers associated with 
cancer and adenomas plus a FIT with published performance characteristics (Wolf, 
Fontham et al. 2018). It was approved by the FDA in 2014 for screening men and women 
aged 50 or older with an average risk of CRC. Effective October 9, 2014, Medicare 
covered the stool DNA test with no co-insurance or Part B deductible for Medicare 
beneficiaries aged 50 to 85 who do not have symptoms of colorectal cancer or an 
increased risk of colorectal cancer. The test is covered by Medicare at three-year 
intervals, as it is considered an acceptable testing modality by USPSTF (US Preventive 
Services Task Force 2016). According to a large, manufacturer-funded, multicenter, 
comparative trial of DNA and FIT testing in average risk individuals, the sensitivity for 
detecting colorectal cancer is 92% with DNA testing and 74% with FIT. The sensitivity 
for detecting advanced precancerous lesions is 42% with DNA testing and 24% with FIT. 
Moreover, specificities with DNA testing and FIT are 87% and 95%, respectively 
(Imperiale, Ransohoff et al. 2014).  
 
 
2.4 Conceptual Framework 
Individuals who wish to receive CRC screenings face multiple barriers. Previous 
studies have identified the patient, provider, and health care system-level barriers to CRC 
screening (McLachlan, Clements et al. 2012, Ramdass, Petraro et al. 2014, Bromley, May 
et al. 2015, Wang, Qiu et al. 2018). In this study, we will focus on colonoscopy among 




method, because a colonoscopy allows doctors to examine the entire length of the colon 
and remove all cancers and precancerous polyps in the same procedure (Levin, 
Lieberman et al. 2008, Rex, Johnson et al. 2009, Wolf, Basch et al. 2016, Benard, Barkun 
et al. 2018). However, one of the most significant barriers to CRC screening is out-of-
pocket financial costs (Howard, Guy et al. 2014); and this is especially true for 
colonoscopies because of relatively high cost-sharing requirements (Klabunde, Riley et 
al. 2004, Hamman and Kapinos 2015). Therefore, it is critically important to know 
whether reduction of financial barriers can improve coverage of colonoscopies.  
This study intended to identify the effects of cost-sharing reduction on the receipt 
of colonoscopies among the elderly as a result of ACA implementation. The analytical 
approach adopted for this analysis was the standard demand theory. Demand for 
colonoscopies is influenced by many factors. The major purpose of demand analysis for 
health care was to determine those factors which, on the average, most affect a person’s 
utilization of health services. Demand analysis seek to identify which factors are most 
influential in determining how much care people are willing to purchase. Consumers 
purchase goods or services for their utility. If the commodity demanded by consumers is 
good health, then health can be produced by goods and services purchased in the market. 
Demand for medical care is derived from the more basic demand for health (Muurinen 
1982).  
According to Grossman (1972), the Demand for Health Model extended the 
human capital theory by explicitly incorporating health and recognizing that there are 
both consumption and investment reasons for investing in health (Grossman 1972). The 




makes the consumer feel better; and (2) that health is an investment commodity, so a state 
of health is determined the amount of time available to the consumer of productivity 
(Grossman 1972).  
Demand for colonoscopies can be explained using a number of factors, such as 
price, price of substitutes, age, gender, income, educational attainment, and other factors, 
indicating individual preferences and propensity to assume risks (Benarroch-Gampel, 
Sheffield et al. 2012, Centers for Disease Control and Prevention 2013, Courtney, Paul et 
al. 2013, Howard, Guy et al. 2014, Ramdass, Petraro et al. 2014, Hamman and Kapinos 
2015, Partin, Gravely et al. 2016, Grzywacz, Hussain et al. 2017). Therefore, the demand 
function can be written as follows: 
 
Demand for Colonoscopy= f (Price, Price of substitutes, Income, Age groups, Gender, 
Educational attainment, supply, Access, Other factors) 
 
The standard demand theory states that, all other factors being equal, as the price 
of a good or service increases, demand for the good or service will decrease, and vice 
versa. The demand curve shows the relationship between the price of a product or service 
and the quantity of the product or service demanded. Price changes in colonoscopies lead 
to movements along demand curve (Howard, Guy et al. 2014, Hamman and Kapinos 
2015). Henry and colleagues (2007) conducted a cost analysis of colonoscopy using 
micro-costing and time-and-motion techniques to determine the total societal cost of 




colonoscopy was $379 (Henry, Ness et al. 2007). Pyenson and colleagues investigated 
the cost of colonoscopy screening for average-risk individuals receiving Medicare, and 
they reported that the 2015 average Medicare colonoscopy screening costs of $1,035 
(Pyenson, Pickhardt et al. 2015). Pyenson and colleagues (2014) determined the costs 
related with colonoscopy in the commercial and Medicare populations and confirmed that 
the average allowed amount for a screening colonoscopy was $2,146 in the commercial 
population and $1,071 in the Medicare population, with average cost sharing of $334 the 
commercial population and $275 in the Medicare population (Pyenson, Scammell et al. 
2014). Consistent with the ACA policy requirement, beginning January 1, 2011, 
Medicare waived Part B deductibles for all colonoscopies and eliminated coinsurance for 
screening colonoscopies (Howard, Guy et al. 2014, Hamman and Kapinos 2015). 
Therefore, demand for colonoscopies is expected to increase with cost-sharing 
reductions.  
“Substitutes” means other goods or services which satisfy the same wants, or 
provide same characteristics, as something else. There are several substitutes that 
individuals can utilize instead of colonoscopies. A number of screening tests exist to 
detect early-stage CRC and prevent incident cases, including flexible sigmoidoscopy, 
FIT-DNA, fecal occult blood tests, fecal immunochemical tests, CT colonography, 
flexible sigmoidoscopy plus FIT, and colonoscopies (US Preventive Services Task Force 
2016, Wolf, Fontham et al. 2018). The USPSTF recommends screening via an accepted 
method because any screening is better than no screening at all (Atkin, Edwards et al. 




other CRC screening tests can affect demand for colonoscopies. If the price of other CRC 
screening tests increase, demand for colonoscopies is expected to increase.   
According to the model (see figure 1), individuals inherit a stock of health when 
they are born. Health depreciates over time; however, an individual may able to slow this 
decline through an investment in health. As we age, our health stock depreciates faster; 
that is, the depreciation rate rises from δ0 to δ1 to δD. The result of aging in this model is a 
continuously falling optimal level of health stock. Age may also shift the marginal 
efficiency of investment (MEI) curve to the left, because the returns from an investment 
will last for a shorter period of time. This will reinforce the decrease in investment that 
occurs due to increased depreciation. As people’s age advances, they experience an 
increase in the rate of illness and in the utilization of health services. The stock of health 
can be maintained by investments to sustain health, including use of colonoscopies. Over 
the life cycle, individuals will try to offset part of the increased rate of depreciation in 
their stock of health by increasing their expenditure on health. Therefore, demand for 
colonoscopies is expected to increase with aging. Previous studies have shown that being 
in the upper age-range of screening guidelines is associated with higher rates of screening 
colonoscopy (Centers for Disease Control and Prevention 2013, Ramdass, Petraro et al. 
2014). Ramdass and colleagues (2014) found that individuals aged 61 to 70 years and 71 
to 80 years were significantly more likely to have had a screening colonoscopy within the 
past 10 years when compared to individuals aged 50 to 60 years (Ramdass, Petraro et al. 
2014). 
Increased wage rates increase the returns obtained from days of good health. For 




$200 rather than $150. Therefore, higher wages imply a higher MEI curve, or MEI'. The 
higher wage will imply a higher optimal level of health stock in the pure investment 
model. The rewards of being healthy are greater for higher-wage workers, so increased 
wages will tend to increase workers’ optimal health capital stock. It is now optimal to 
increase health stock from H0 to H2. If consumers’ income increases, then any given 
price, the consumers are willing and able to purchase more goods or services. Therefore, 
the demand for colonoscopies will increase with increases in individuals’ income. 
Benarroch-Gampel and colleagues (2012) showed that there was a strong association 
between colonoscopy use and income, with higher income groups associated with higher 
colonoscopy use (Benarroch-Gampel, Sheffield et al. 2012).  
 
  





The effect of education is also illustrated in Figure 1. Here, the MEI curve shows 
the marginal efficiency of investment for the consumer with a low level of education, 
while the MEI' curve shows the same person with a higher level of education. Education 
raises the marginal product of the direct inputs; it reduces the quantity of these inputs 
required to produce a given amount of gross investment. Education is seen as improving 
the efficiency of producing health, which shifts the MEI curve to the right. More highly 
educated people will choose higher optimal health stocks, H2, than will less educated 
people, who will choose H0. On the other hand, highly educated individuals are also likely 
to recognize the benefits of improved health. They may also enjoy performing physical 
exercise or eating healthy food. They may recognize the effects of unhealthy lifestyles, 
including smoking cigarettes and drinking alcohol. They may enjoy feeling and looking 
good. As such, all else equal, educated individuals will have a greater taste for health 
relative to other goods. Therefore, the demand for colonoscopies is expected to increase 
with higher education. Previous studies have shown that individuals with higher levels of 
educational attainment are more likely to have had screening colonoscopy (Centers for 
Disease Control and Prevention 2013, Ramdass, Petraro et al. 2014). 
Demand for colonoscopies is affected by gender. Previous studies have shown 
that being male is associated with higher levels of screening colonoscopy (Partin, 
Gravely et al. 2017). Partine and colleagues (2016) found that women are less likely to 
have had a colonoscopy screening than men (Partin, Gravely et al. 2016). Ramdass and 
colleagues (2014) found that men were 2.71 times more likely than women to have had a 




Demand for colonoscopies is affected by location of services. Previous study has 
shown that people who live in urban areas are 1.13 times more likely to miss colonoscopy 
than people who live in rural or highly rural areas (Partin, Gravely et al. 2016). Eberth 
and colleagues (2017) confirmed that there has been substantial growth over time in the 
number of facilities and physicians performing colonoscopies in South Carolina, although 
certain improvements have been limited to urban counties. For example, the number of 
gastroenterologists with a primary office location in rural South Carolina has declined by 
13%, whereas urban counties experienced a 17% increase (Eberth, Josey et al. 2017). 
Demand for colonoscopies is affected by factors determined by provider and 
supply of services. Previous studies have demonstrated that physician supply has been 
associated with increased use of colonoscopies (Brouse, Wolf et al. 2008, Haas, 
Brawarsky et al. 2010, Benarroch-Gampel, Sheffield et al. 2012, Eberth, Josey et al. 
2017). Benarroch-Gampel and colleagues (2012) examined the influence of colonoscopist 
and primary care physician supply on racial disparities in receipt of colonoscopy and 
found that while increasing colonoscopist and primary care physician capacity was 
associated with increased colonoscopy use in whites, but it was associated with decrease 
in colonoscopy use in blacks and Hispanics (Benarroch-Gampel, Sheffield et al. 2012). 
One of the most powerful factors in increasing adherence to CRC screening is provider 
recommendation (Ramdass, Petraro et al. 2014, Peterson, Ostroff et al. 2016). A 
systematic review has shown that provider recommendation significantly improves 
screening rates (Peterson, Ostroff et al. 2016).Researchers have also found that offering 
patients a choice of CRC screening through shared decision making, rather than 




2012, Wolf, Fontham et al. 2018). Furthermore, provider recommendation has been 
associated with an increase in use of screening colonoscopy (Ramdass, Petraro et al. 
2014). In fact, Ramdass and colleagues (2014) found that provider recommendation for 
colonoscopies is the most effective strategy to promote colonoscopy screening in the US 
(Ramdass, Petraro et al. 2014). 
Demand for colonoscopies is affected by time and travel costs (Petryszyn, 
Kempinski et al. 2014). Higher time-cost effectively increases the price of the product. A 
colonoscopy requires a clinic visit. Henry and colleagues (2007) conducted a cost 
analysis of colonoscopies using micro-costing and time-and-motion techniques to 
determine the total societal cost of colonoscopies, including direct health care costs as 
well as direct non-health care costs, and costs related to patients’ time (Henry, Ness et al. 
2007). The median direct non-health care costs (travel costs and costs of caregivers’ time) 
was $226, and indirect costs (related to patient time) was $274 (Henry, Ness et al. 2007). 
These time and travel costs may affect demand for colonoscopies. Frew and colleagues 
(1999) examined 3,525 respondents from 12 clinical centers in Great Britain that had 
carried out flexible sigmoidoscopy for CRC screening. 81% respondents traveled to the 
clinic by car, 9% by bus, 4% by taxi, and 2% by train; while 1% walked, and the 
remaining 4% came by other means or a combination of modes. Mean travel times for car 
and taxi users were significantly shorter than travel times for bus users and other modes 
combined. The mean travel cost amounted to $6.10 per person. Mean total time and 
travel cost was estimated for a subject as $16.90 and for a screening attendance as 
$22.40. By attending clinic-based screening, self-employed individuals lose their 




Wolstenholme et al. 1999). Moreover, Dong and colleagues (2011) assessed the patterns 
and reasons for missed work related to colonoscopy screenings and found that 34% of 
working individuals missed work more than one day when their screening was conducted 
on a Tuesday, Wednesday, or Thursday. They also found that 32% of workers took sick 
leave or vacation leave on the day prior to the colonoscopy, mainly in anticipation of the 
bowel preparation; 10% took sick or vacation leave the day after the colonoscopy, 
primarily as a precautionary measure following sedation rather than in response to true 
symptoms; and 9% took leave days both before and after the day of the colonoscopy. 
Moreover, colonoscopy procedures require a significant amount of time investment from 
friends and family members. 45% of individuals had friends or family members who also 
took leave time for the procedure (Dong, Kalmaz et al. 2011). Dong and colleagues 
suggested that these costs may be diminished through patient education about bowel 
preparation and what to expect before and after the procedure, and by scheduling more 
screening colonoscopies on Monday and Fridays (Dong, Kalmaz et al. 2011).  
Demand for colonoscopies is affected by tastes and preferences. Previous studies 
have demonstrated that female patients have a preference for female gastroenterologists 
for office visits and colonoscopies (Menees, Inadomi et al. 2005, Shah, Karasek et al. 
2011, Chong 2012). The main reason for this sex preference is embarrassment, and a 
higher level of education is a significant factor in patient embarrassment. Shah and 
colleagues (2011) confirmed that more than 30% of female patients would avoid 
receiving a colonoscopy if they were unable to have a physician of their sex preference 
(Shah, Karasek et al. 2011). Menees and colleagues (2011) also confirmed that 43% of 




be willing to wait more than 30 days to access a female colonoscopist (Menees, Inadomi 
et al. 2005). Therefore, patient sex preference may affect demand for colonoscopies. 
According to a systematic review and meta-analysis study conducted by Lin and 
colleagues (2012), patients preferred CT colonography over colonoscopy, and limited 
bowel preparations for CT colonography may be the reason for CT colonography 
preference (Lin, Kozarek et al. 2012).  
Demand for colonoscopies is affected by quality of care. The benefit and risks of 
different screening options vary (Knudsen, Zauber et al. 2016, US Preventive Services 
Task Force 2016). The USPSTF detailed the estimated number of life years gained, CRC 
deaths averted, lifetime colonoscopies required, and resulting complications per 1,000 
screened adults aged 50 to 75 for each of the screening strategies (Knudsen, Zauber et al. 
2016, US Preventive Services Task Force 2016). Across the different screening methods, 
colonoscopies showed highest number of life years gained and CRC deaths averted per 
1,000 screened adults aged 50 to 75. On the other hand, colonoscopies also had highest 
lifetime colonoscopies required and complications (gastrointestinal and cardiovascular 
events) of CRC screening and follow-up testing per 1,000 screened adults aged 50 to 75 
years across the different screening methods (US Preventive Services Task Force 2016). 
Colonoscopies vary by quality, and high-quality colonoscopies take considerably more 
time than the average time physicians spend on colonoscopies (Vicari 2010, Keswani, 
Yadlapati et al. 2015, Bitar, Zia et al. 2018). The screening tests have differing levels of 
evidence supporting their effectiveness, as well as distinct strengths and limitations, and 




Demand for colonoscopies is affected by awareness level. Ricardo-Rodrigues and 
colleagues (2014) examined awareness levels of colonoscopies as a screening option for 
CRC, its uptake, and possible associated factors in confirmed individuals from lower 
socioeconomic groups or those who only had primary education or who showed a lower 
level of awareness (Ricardo-Rodrigues, Hernandez-Barrera et al. 2014). Hermann and 
colleagues (2015) argued that organized CRC screening groups should build a written 
invitation system to reduce the sociodemographic-related differential awareness and 
colonoscopy uptake (Hermann, Friedrich et al. 2015). Pelto and colleagues (2015) 
confirmed that health education and patient navigation programs that increase awareness 
of the benefits of colonoscopies may encourage colonoscopy completion. In the context 
of language-appropriate patient navigation programs for African-American and Latino/a 
individuals, those with lower incomes and English as a second language speakers may 
require additional education and counseling to support their decision-making about 
having colonoscopies (Pelto, Sly et al. 2015). Therefore, the demand for colonoscopies is 
expected to increase with higher awareness levels of colonoscopies.  
Demand for colonoscopies is affected by time preference. Future costs and 
benefits must be discounted to put them on an equal basis with present values. 
Individuals with a high discount rate will be more likely to prefer projects with 
immediate payoffs rather than long-term projects. Both education and health require 
current outlays to gain distant payoffs. Individuals with lower discount rates will assign 
value to the future and will be more likely to invest in both education and health by 
receiving cancer screenings. Therefore, the demand for colonoscopies is expected to 




Previous studies have confirmed that demand for colonoscopies is influenced by 
many factors, including price, price of substitute procedures, age, gender, income, 
educational attainment, and supply of providers (Benarroch-Gampel, Sheffield et al. 
2012, Centers for Disease Control and Prevention 2013, Courtney, Paul et al. 2013, 
Howard, Guy et al. 2014, Ramdass, Petraro et al. 2014, Hamman and Kapinos 2015, 
Partin, Gravely et al. 2016, Grzywacz, Hussain et al. 2017). In this study, we examined 
how the ACA cost-sharing reduction has changed colonoscopy use among the elderly 
insured and assessed the various factors that affect receipt of colonoscopies. 
 
 
2.5 Significance  
Beginning in September 2010, the ACA required all non-grandfathered private 
health plans to offer coverage of CRC screenings without cost-sharing to address the 
negative consequences of financial barriers on the use of preventative services and to 
promote CRC screening. Consistent with the ACA policy requirement, beginning January 
1, 2011, Medicare waived Part B deductibles for all colonoscopies and eliminated 
coinsurance for screening colonoscopies, though not for therapeutic ones (Howard, Guy 
et al. 2014, Hamman and Kapinos 2015). This study investigated the effect of the ACA’s 
removing of financial barriers on the receipt of colonoscopies among insured elderly, 
who are predominantly covered by Medicare. Moreover, this study examined how 
income-related disparities in colonoscopy use have changed over the past decade and 




colonoscopies among insured elderly. Our hypothesis was that the elderly insured 
population have a greater likelihood of undergoing colonoscopies following the 
implementation of the ACA. We also wanted to determine whether the ACA policy 
changes have helped the socioeconomically vulnerable elderly more than others. 
Researchers and policy makers have studied the effects of cost-sharing reductions 
on the utilization of preventive health care in great detail, but surprisingly, only a few 
studies have assessed the effect of cost-sharing reductions on colonoscopies among 
elderly insured (including Medicare beneficiaries), following the implementation of the 
ACA (Hamman and Kapinos 2015, Cooper, Kou et al. 2016).  
The few studies that examined this issue have used a very short time-frame 
beginning with the implementation of the ACA, so these studies may underestimate the 
effects of policy changes over time. Furthermore, these studies show varied results on the 
receipt of colonoscopies following the changes in coverage post-ACA (Fedewa, 
Goodman et al. 2015, Hamman and Kapinos 2015, Cooper, Kou et al. 2016); and they 
have not been able to determine whether eliminating financial barriers have helped the 
socioeconomically vulnerable Medicare beneficiaries more than other groups. It is true 
that some of the socioeconomically vulnerable elderly may be enrolled in Medicaid; in 
which case they would have received colonoscopies without any out-of-pocket expenses 
even in pre-ACA years. However, this should not affect the results significantly as almost 
all elderly are enrolled in Medicare and only a small percentage are enrolled in Medicaid 
(Medicaid only or dually eligible) (Grabowski 2012).  
Five cycles (2008, 2010, 2012, 2014, and 2016) of the Behavioral Risk Factor 




among insured elderly aged 65 to 75 prior to the implementation of ACA and then again 
afterwards. Previous studies, using BRFSS from the years 2008, 2010, and 2012, has 
assessed the effect of cost-sharing reduction on colonoscopies among Medicare 
beneficiaries following the implementation of the ACA (Hamman and Kapinos 2015). 
One study  used BRFSS to examine trends in breast and CRC screening in the U.S. by 
race, healthcare coverage, and socio-economic status before the Great Recession (2003-
2005), during the recession (2007-2009), and at the beginning of the ACA period (2010-
2012) (Wyatt, Pernenkil et al. 2017). Both these studies used a very short time frame 
beginning with the implementation of the ACA, so the studies may underestimate the 
effects of policy changes. 
This study will contribute to advancing knowledge about the effect of reduction in 
cost-sharing on the receipt of colonoscopies among the elderly insured. It is critically 
important to know whether reduction of financial barriers alone can improve adherence to 
CRC screenings in order to achieve the national goal of 80% by 2018 target and the 
HP2020 goal of 71%. Reduction in financial expenses alone may not be enough to reach 
the goal, in which case these analyses will be able to indicate other policy options for 
improving coverage of colonoscopies. The study will provide scientific evidence on 
effect of cost-sharing reduction on the receipt of colonoscopies among the elderly insured 
as well as other policy options for improving adherence to CRC screening.  
Under current law, Medicare waives coinsurance and deductibles for 
colonoscopies. However, when a polyp is discovered and removed, the procedure is 
reclassified as therapeutic for Medicare billing purposes; and beneficiaries become 




unexpected out-of-pocket liabilities when a polyp is detected and removed during a 
colonoscopy. The Removing Barriers to Colorectal Cancer Screening Act of 2017 (H.R. 
1017/S. 479) is designed corrected this oversight in current law, but it has yet to become 
a formal law. The study will provide supportive evidence to show the benefits of cost-







This study aimed to examine the changes in colonoscopy use among the elderly 
insured population, including Medicare beneficiaries, following the implementation of 
the ACA policy for preventive services. Our hypothesis was that the elderly insured 
population have a greater likelihood of undergoing colonoscopies following the 
implementation of the ACA. We also wanted to determine whether the ACA policy 
changes have helped the socioeconomically vulnerable elderly more than others. The first 
manuscript of the dissertation examined the effect of the ACA cost-sharing reduction on 
the receipt of colonoscopy among the elderly insured population. This study aimed to 
examine how the ACA cost-sharing reduction has changed colonoscopy use among the 
elderly insured and to assess the various factors that affect the receipt of colonoscopies. 
The second manuscript examined how disparities in colonoscopy use in the United States 
have changed over the past decade, in line with the implementation of the ACA and 
attempted to quantify the contributions to the disparity in the use of colonoscopies among 





3.1 Methods for Manuscript 1 
3.1.1 Data and participants  
This study used 2008-2016 BRFSS data, an annual, nationally representative 
survey implemented in the United States, the District of Columbia, Puerto Rico, Guam, 
the US Virgin Islands, American Samoa, and Palau. BRFSS uses random-digit telephone 
dialing methods to sample noninstitutionalized adults aged 18 years or older (Kirchhoff, 
Lyles et al. 2012, Schneider, Clark et al. 2012). The BRFSS is the largest ongoing public 
health survey in the world; in 2016, the number of completed interviews was 486,303. 
The objective of BRFSS is to collect uniform, state-specific data on health risk behaviors, 
chronic diseases and conditions, access to health care, and use of preventive health 
services in the United States.  
In 2011 BRFSS added cellular telephone households to adjust for the rapidly 
rising percentage of individuals and households in the US with cellular telephones but no 
landlines. BRFSS also adopted new methods of weighting to adjust survey data for 
differences between the demographic characteristics of respondents and target 
populations. Therefore, these two considerations were implemented during the fielding of 
the 2011 BRFSS. Since 2011, a new methodology called iterative proportional fitting 
(“raking”) replaced the poststratification method to weight BRFSS data (Centers for 
Disease Control and Prevention 2012). Raking permits incorporation of cellular 
telephone survey data and allows the introduction of additional demographic 
characteristics in addition to age-race/ethnicity-gender that improves the degree and 




individual states. Preliminary assessments show that the inclusion of cellular telephone 
respondents and the change to a new method of weighting may increase prevalence 
estimates for health risk behaviors and chronic disease in many states. Although raking 
might cause state prevalence trends for certain risk factors to shift upward, in general, the 
shape of trend lines over time may not be significantly affected (Centers for Disease 
Control and Prevention 2012).   
In 2008 the BRFSS began including questions about colonoscopies in even years. 
Therefore, this study used data from the years 2008, 2010, 2012, 2014, and 2016. 
Previous studies, using BRFSS from the years 2008, 2010, and 2012, has assessed the 
effect of cost-sharing reduction on colonoscopies among Medicare beneficiaries 
following the implementation of the ACA (Hamman and Kapinos 2015). One study  used 
BRFSS to examine trends in breast and CRC screening in the U.S. by race, healthcare 
coverage, and socio-economic status before the Great Recession (2003-2005), during the 
recession (2007-2009), and at the beginning of the ACA period (2010-2012) (Wyatt, 
Pernenkil et al. 2017). Both these studies used a very short time frame beginning with the 
implementation of the ACA, so the studies may underestimate the effects of policy 
changes. The sample for this study consists of noninstitutionalized, insured elderly aged 
65 to 75 who participated in the survey. For our analyses, only those insured who were in 
the age group 65 to 75 years were included, bringing the sample size down to 446,981 
adults. We excluded individuals with missing values for variables of interest and those 
who refused to answer questions relevant in creating the main measures for the study. 
Thus, the analysis sample consisted of 349,899 participants (144,628 men and 205,271 




cases. Table 3.1 presents a study of the analysis sample of 349,899 participants, aged 65 











Table 3.1 BRFSS sample compared to the overall U.S. Medicare population 
Characteristic 




Total 100 Total 100 
Age (years)  Age (years)  
65-66 23 <65 17 
67-68 21 65-74 46 
69-70 19 75-84 25 
71-72 16 85+ 13 
73-75 22  
 
Sex  Sex  
Male 48 Male 46 
Female 52 Female 54 
Race/ethnicity  Race/ethnicity  
Non-Hispanic White 79 Non-Hispanic White 75 
Non-Hispanic Black 9 Non-Hispanic Black 9 
Hispanic 7 Hispanic 10 
Other 5 Other 6 
Region of Residence  Region of Residence  
Northeast 18 Urban 77 
Midwest 22 Rural 23 
South 38  
 
West 22  
 
Household income  Household income  
Less than $15,000 10 Below poverty 16 
$15,000 to less than $25,000 19 100-125% of poverty 8 
$25,000 to less than $35,000 14 125-200% of poverty 20 
$35,000 to less than $50,000 18 200-400% of poverty 30 
$50,000 or more 39 Over 400% of poverty 25 
Education  Education  
Did not graduate high school 12 Did not graduate high school 20 
Graduated High School 30 Graduated High School 27 
Attended College 28 Some colleague or more 52 
Graduated from College 29  
 
General health status 
 
General health status 
 
Excellent/ Very good 46 Excellent/ Very good 45 
good/ fair 47 good 47 
Poor 7 Fair/Poor 8 
Source: MedPAC analysis of the Medicare Current Beneficiary Survey, Cost and Use file 2013 
 
Most Medicare beneficiaries are female and White. More precisely, 54% of the 
Medicare population is female and 52% of the BRFSS sample population was female. 
75% of the Medicare population is non-Hispanic White and 79% of the BRFSS sample 




school diploma, but the BRFSS sample showed that 12% of elderly insured have no high 
school diploma. Most beneficiaries reported fair to excellent health. Only 8% of the 
Medicare population reported poor health; similarly, only 7% of the BRFSS sample 
population reported poor health. The BRFSS sample from 2010 to 2016 showed that only 
13% of elderly insured have an any types of cancer of any type. However, since there is 
no cancer information in is available for 2008, we did not include a cancer status variable 
as a covariate.       
 
 
3.1.2 Variables needed for analyses 
Dependent variables 
The outcome of interest in our study is the self-reported receipt of colonoscopies 
in the previous 10 years. In this study, we will focus on the choice of colonoscopy as 
opposed to other recommended CRC screening methods. Colonoscopy is the preferred 
screening method because a colonoscopy allows doctors to examine the entire length of 
the colon and remove all cancers and precancerous polyps in a single procedure (Levin, 
Lieberman et al. 2008, Rex, Johnson et al. 2009, Wolf, Basch et al. 2016, Benard, Barkun 
et al. 2018). A respondent is considered to have received a colonoscopy if he or she 
answered “colonoscopy” to the question, “was your last test a sigmoidoscopy or 
colonoscopy?”. To determine the years within which the colonoscopy was received, the 
responses to the following question was used: “How long has it been since you had your 




dichotomous measure of whether an individual was up-to-date with the USPSTF 
screening recommendation. During our study period, the guideline recommended a 
colonoscopy be performed once within the previous 10 years. Figure 3.2 shows the 
conceptual framework for the current study.  
 
 
Figure 3.2 Conceptual framework for the current study. 
 
Independent variables 
Based on previous studies (Benarroch-Gampel et al., 2012; Cooper et al., 2016; 
Hamman & Kapinos, 2015(Ramdass, Petraro et al. 2014)), our analysis included 
demographic variables (age, sex, race and ethnicity, marital status, and region of 




five categories: 65-66; 67-68; 69-70; 71-72; and 73-75. Sex is classified into two 
categories: male and female. We have incorporated a race and ethnicity variable using the 
following discrete categories: non-Hispanic white, non-Hispanic Black, Hispanic, and 
other. Marital status is classified into two categories: married and other (divorced, 
widowed, separated, never married, and unmarried couple). Region of residence is 
classified into four broad geographic regions of the country based on FIPS codes: 
Northeast, Midwest, South, and West.  
We included two socioeconomic variables in the model as well (household 
income and educational attainment). Household income has been reported using the 
following income classes: lower than $15,000; $15,000 to $25,000; $25,000 to $35,000; 
$35,000 to $50,000; and higher than $50,000. Educational attainment is grouped into four 
categories: did not graduate high school; graduated high school; attended college; and 
graduated from college. 
We pooled all five cycles of the survey into one large data set. The data set 
includes individual surveys conducted in two years prior to the ACA policy change (2008 
and 2010) and three years after (2012, 2014, and 2016). Medicare, the predominant 
insurance provider among elderly, waived deductibles for colonoscopies and eliminated 
coinsurance requirements effective January 1, 2011. To capture the effect of policy 
change on the receipt of colonoscopies, a policy-shift dummy variable was introduced 
into the model. 
We used geographic availability of gastroenterologists and degree of health 




colonoscopies. The American Medical Association (AMA) Health Workforce Mapper 
reports the availability of different specialists by state, and we have used the reported 
number of professionally active gastroenterologists (GI) by state to calculate the 
geographic availability of GIs per 1000 individuals in a given population. We reported 
the geographic availability of gastroenterologists as a quartile of gastroenterologist 
availability, meaning we divided the distribution of the variable into four groups having 
equal frequencies. The hypothesis was that receipt of colonoscopies will be affected by 
the availability of colonoscopy providers in the area. Previous studies have demonstrated 
that physician supply has been associated with increased use of colonoscopy (Haas, 
Brawarsky et al. 2010, Benarroch-Gampel, Sheffield et al. 2012, Eberth, Josey et al. 
2017). A recent study reported that the estimated colonoscopy capacity was sufficient to 
screen 80% of the eligible U.S. population (Joseph, Meester et al. 2016). 
BRFSS does not have any direct measure of individuals’ awareness of 
colonoscopy as a screening option or the importance assigned by individuals to 
preventive services which have little or no current benefits but improve future health. 
One of the concerns in estimating the effect of a policy change over many years is that 
during that time, individuals may become more aware of the importance of 
colonoscopies, as well as other preventive services. Over the years, the awareness level 
may improve due to on-going campaigns to popularize the use of colonoscopies as an 
effective approach in preventing CRC. If we assume that knowledge about all preventive 
services are interrelated, “effective” use of one or more preventive actions will imply 
improvements in knowledge about the importance of colonoscopies. We have decided to 




status. Adoption of physical exercise reflects an individual’s willingness to accept a 
preventive activity to improve health in the future. Since participation in physical 
exercise represents individual’s willingness to spend resources (time and energy) now for 
the betterment of health in the future, it may be considered an indirect measure of the 
degree of importance the individual assigns to other preventive services like 
colonoscopies. Smoking status is a more complex proxy measure, probably reflecting an 
individual’s long-term perspective on future health status and the implicit time discount 
rate. Smokers are likely to discount future years at a much higher rate than non-smokers 
and former smokers. Those with lower time preference rates (lower discount rates) are 
more likely to adopt preventive interventions and screenings (Axon, Bradford et al. 2009, 
Bradford 2010). We differentiated the individuals in the sample as those who reported 
physical exercise within the past 30 days and those who did not. Smoking status was 
categorized into three groups: current smoker, former smoker, and never smoked. 
 
3.1.3 Statistical analyses 
Descriptive statistics were used to summarize participant characteristics and to 
report the number and percentage of participants for each of the variables. In addition, we 
reported the percentage of respondents who had a colonoscopy in the previous 10 years 
by pre- and post-ACA policy change. We reported the percentage change instead of 
actual change as the percentage change method more precisely depicts the changes in 
data over a period of time. Bivariate and multivariate logistic models were used to 
estimate the effects of reduction in cost-sharing the receipt of colonoscopies among 




demographic characteristics (age, sex, race/ethnicity, marital status, and region of 
residence), socioeconomic status (household income and educational attainment), 
geographic availability of gastroenterologists, health awareness proxies (exercise and 
smoking status), and the policy change shifter variable.  
The empirical model is as follows:  
The receipt of colonoscopy (Yij) = 𝛽0𝑗 + 𝛽1𝑗 (patient age) + 𝛽2𝑗 (patient gender) 
+ 𝛽3𝑗 (patient race and ethnicity) + 𝛽4𝑗 (patient marital status) + 𝛽5𝑗 (region of resident) + 
𝛽6𝑗 (household income) + 𝛽7𝑗 (educational attainment) + 𝛽8𝑗 (gastroenterologist 
availability) + 𝛽9𝑗 (Exercise) + 𝛽10𝑗 (smoking status) + 𝛽11𝑗 (policy change) + 𝛾𝑖𝑗 
 
This model is estimated to reveal the association between Medicare’s cost-sharing  
reduction provision and the receipt of colonoscopies among elderly insured aged 65 to 
75. We hypothesize that, controlling for observable patient and area resource differences, 
elderly insured have a greater likelihood of undergoing colonoscopies following the 
implementation of ACA. The primary outcome is the receipt of a colonoscopy within the 
previous 10 years, defined as a dichotomous measure of whether an individual was up-to-
date with the USPSTF screening recommendation. During our study period, the guideline 
recommended that one colonoscopy be completed within the past 10 years. We expected 
that elderly insured have a greater likelihood of undergoing colonoscopies following the 
implementation of the ACA. All statistical analyses were performed using SAS version 






3.2 Methods for Manuscript 2 
3.2.1 Data and participants  
This study used 2008-2016 BRFSS data, an annual, nationally representative 
survey implemented in the United States, the District of Columbia, Puerto Rico, Guam, 
the US Virgin Islands, American Samoa, and Palau. BRFSS uses random-digit telephone 
dialing methods to sample noninstitutionalized adults aged 18 years or older (Kirchhoff, 
Lyles et al. 2012, Schneider, Clark et al. 2012). The BRFSS is the largest ongoing public 
health survey in the world; in 2016, the number of completed interviews was 486,303. 
The objective of BRFSS is to collect uniform, state-specific data on health risk behaviors, 
chronic diseases and conditions, access to health care, and use of preventive health 
services in the United States.  
In 2008 the BRFSS began including questions about colonoscopies in even years. 
Therefore, this study used data from the years 2008, 2010, 2012, 2014, and 2016. 
Previous studies, using BRFSS from the years 2008, 2010, and 2012, have assessed the 
effect of cost-sharing reduction on colonoscopies among Medicare beneficiaries 
following the implementation of the ACA (Hamman and Kapinos 2015). One study using 
BRFSS examined trends in breast and CRC screening in the U.S. by race, healthcare 
coverage, and socio-economic status before the Great Recession (2003-2005), during the 
recession (2007-2009), and at the beginning of the ACA period (2010-2012) (Wyatt, 
Pernenkil et al. 2017). Both these studies used a very short time frame beginning with the 




changes. The sample for this study consists of noninstitutionalized, insured elderly aged 
65 to 75 who participated in the survey from the years 2008, 2010, 2012, 2014, and 2016. 
For our analyses, only those insured who were in the age group 65 to 75 years were 
included, bringing the sample size down to 446,981 adults. We excluded individuals with 
missing values for variables of interest and those who refused to answer questions 
relevant in creating the main measures for the study. Thus, the analysis sample consisted 
of 349,899 participants (144,628 men and 205,271 women) aged 65 to 75 years.  
 
3.2.2 Definition of the Measures Used 
The variable of interest for the study is the self-reported receipt of a colonoscopy 
in the previous 10 years. A respondent is considered to have received a colonoscopy if 
the individual answered “colonoscopy” to the question, “was your last test a 
sigmoidoscopy or colonoscopy?”. To determine the years within which the colonoscopy 
was received, the responses to the follow-up question were used: “how long has it been 
since you had your last sigmoidoscopy or colonoscopy?”. We defined our outcome 
variable as a dichotomous measure of whether an individual was up-to-date with the 
USPSTF screening recommendation. During our study period, the guidelines 
recommended having a colonoscopy once every 10 years. 
 The literature has identified several sets of variables to explain variations in 
colonoscopy use. We included age, sex, race and ethnicity. Age was categorized into five 
groups: 65-66, 67-68, 69-70, 71-72, and 73-75. Sex was classified into two categories: 




Hispanic white, non-Hispanic Black, Hispanic, and other. We dichotomized marital status 
as married or not married. We described geographic characteristics by census region 
(Northeast, Midwest, South, and West). Based on previous studies (Benarroch-Gampel, 
Sheffield et al. 2012, Hamman and Kapinos 2015, Solmi, Von Wagner et al. 2015, 
Cooper, Kou et al. 2016), our analysis included household income and educational 
attainment. We used a categorical measure of annual household income with the 
following categories: lower than $10,000; $10,000 to $14,999; $15,000 to $19,999; 
$20,000 to $24,999; $25,000 to $34,999; $35,000 to $49,999; $50,000 to $74,999; and 
$75,000 or more. Educational attainment was classified into four categories: did not 
graduate high school; graduated high school; attended college; and graduated from 
college. Racial and ethnic disparities in CRC screening had already been broadly 
documented, and most studies found that individuals belonging to ethnic minorities were 
less likely to adhere to screening guidelines; lower socio-economic status (indicating 
dimensions such as income, education, and employment status) among ethnic minority 
groups is considered the most likely explanation for this finding (Shih, Zhao et al. 2006, 
Benarroch-Gampel, Sheffield et al. 2012, Burnett-Hartman, Mehta et al. 2016, Hong, 
Tauscher et al. 2017). In addition, lower educational attainment is associated with lower 
adherence to CRC screening guidelines (Gimeno Garcia 2012, Kobayashi, Wardle et al. 
2014).   
The final data set generated for this analysis includes two years of information 
prior to the implementation of ACA (2008 and 2010) and three years of information 
following the implementation of ACA (2012, 2014, and 2016). Since a large majority of 




significant impact on the use of CRC. For controlling the time trade-off rates of 
individuals and willingness to spend resources for improving future health status, we 
incorporated two variables in the analysis: whether the individual exercised or not within 
previous 30 days and whether the individual is a current smoker, former smoker, or never 
smoked. 
 
3.2.3 Concentration index 
The concentration index has demonstrated its usefulness as a tool in measuring 
health sector disparities. The concentration index measures the degree of disparity in the 
utilization of various medical care services or outcomes. To estimate the concentration 
index, one variable must be used as the main metric to rank households on the basis of 
levels of living or socioeconomic status. We can use household income as the measure to 
calculate the concentration index in the use of colonoscopies. The standard concentration 








where 𝑛 is the sample size, 𝑦𝑖 is healthcare utilization of individual 𝑖, μ is its mean and 
𝑅𝑖 =  
𝑖
𝑁
  is the fractional rank of individual 𝑖 in household income distribution. For a 
given μ > 0, the maximum of the concentration index is when the poorest 𝑖 individuals 




equal to 1. In this case, the value of CI will be maximum at +11. If the poorest person 
uses CRC screening and not anyone else, the CI will have the value of -1. If the richest 
person uses CRC screening and not anyone else, the CI will have the value of +1. If CI 
equals zero, then there is no income-related disparity in the distribution of CRC 
screening. As this analysis have used a binary response indicating whether or not a 
insured elderly had a recommended colonoscopy, normalized concentration index 
employing the Wagstaff decomposition method was applied (Wagstaff 2005). Standard 
errors for the normalized index correct for both autocorrelation and heteroscedasticity 






3.2.4 Statistical analyses 
We first compared the difference in concentration index between the pre- and 
post-ACA periods. Decomposition analysis of the concentration index was used to 
determine the impact of a range of sociodemographic variables on any disparity in 
colonoscopy use. It was based on the partitioning of total disparity into the precise 
disparities observed by each individual regressor (van Doorslaer, Koolman et al. 2004). A 
logistic regression was applied with a linear estimation to allow for the correct 
decomposition. The following equation shows the linear estimation of the logistic results 
                                                          
1 𝐶𝐼 = 2
𝑛μ
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𝑛  are the average partial effects of each variable (𝑥) – yielding the likelihood of 
a screening colonoscopy (𝑦).         





The following equation shows the decomposition analysis comprised of average 
partial effects of each 𝑥 as well as their means and individuals concentration index. In 
this equation, the first expression shows the contribution of equivalized income, the 
second expression shows effect of other socio-demographic variables perceived to 














We presented CIs prior to the ACA policy change (2008 and 2010) and after ACA 
implementation (2012, 2014, and 2016). We identified the largest determinant of 
disparity observed in pre-ACA years and post ACA years.  Positive values of the overall 
CIs suggest that colonoscopy use was concentrated among individuals with higher 
household incomes. CIs were broken down by confounder and represented as 
contributions to the overall income-related disparity in the use of colonoscopies with 
percentage contributions in brackets. The percentage contribution is attained by dividing 
the absolute contribution by the overall income-related disparity. We included age, sex, 
race and ethnicity, marital status, household income, educational attainment, region of 





3.3 Ethical approval 
This study was reviewed and deemed exempt by the Institution Review Board at the 
University of South Carolina (See Appendix). 
 
3.4 Limitations 
This study has several limitations. First, the BRFSS is based on self-reports, 
which may be subject to recall bias. True screening rates are more likely less than 50% 
for adults aged 50 or older (Paskett and Khuri 2015). Therefore, one challenge is 
establishing an accurate level of CRC screenings. However, this study was unable to 
perform a cross-check with medical records using current data (Ferrante, Ohman-
Strickland et al. 2008, Schenck, Klabunde et al. 2008). Second, there is also the 
possibility of selection bias in this type of survey, as less healthy patients may not be 
included in the sample. Third, the BRFSS does not include information about actual out-
of-pocket expenditures or other possible determinants of screening such as opportunity, 
cost of time or difficulty in scheduling colonoscopies. Fourth, this study could not 
distinguish between screening and diagnostic colonoscopies. Nonetheless, given the fact 
that around 40% of adults who should receive CRC screenings do not receive them 
(Joseph, King et al. 2012, Hamman and Kapinos 2015, Paskett and Khuri 2015), finding 
an increase in all types of colonoscopies as a result of the Affordable Care Act does 
suggest an improvement in CRC detection. Fifth, gastroenterologists are not only 




et al. 2012, Joseph, Meester et al. 2016). Sixth, there is also the possibility of historical 
threats to validity (e.g. increasing awareness over time and social norms in support of 
CRC). Seventh, this study could not assess awareness of CRC. Finally, in 2011 BRFSS 
changed its weighting methodology with the inclusion of cellular phone-only 
respondents. Cellular phone respondents are likely to be different from others in terms of 
age and risk of CRC. Therefore, this additional approach of selecting respondents may 
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Objectives: The Affordable Care Act (ACA) waived deductibles and eliminated 
coinsurance for colonoscopies for Medicare beneficiaries beginning in January 1, 2011. 
This study investigated the effect of the ACA’s directive to remove the financial barriers 
on the receipt of colonoscopies among the elderly insured, who are predominantly 
covered by Medicare.  
Methods: We used data from the 2008-2016 Behavioral Risk Factor Surveillance System 
(BRFSS), an annual, nationally representative survey, to examine the receipt of 
colonoscopies for two years prior to the implementation of the ACA (2008 and 2010) and 
three years after the change (2012, 2014, and 2016). Multivariate logistic regressions 
were estimated to examine the change in colonoscopy use before and after the ACA, 
adjusting for patient characteristics and availability of health care providers in the 
geographic region. 
Results: Of 349,899 eligible elderly insured in the age group 65 to 75 years, 236,275 
(67.2%) had received a colonoscopy in the previous 10 years. The receipt of 
colonoscopies increased from 63.5% in pre-ACA years to 69.2% in the post-ACA years 
(p<.001). Compared with the pre-ACA period, colonoscopy uptake during post ACA 
years shows an odds ratio of 1.15 (95% confidence limit [CI] = 1.08-1.22, p<.001) after 
adjusting for time dependent improvements in colonoscopies and other relevant factors. 
Conclusions: Following the implementation of the ACA, a statistically significant 




barriers to access has improved the CRC screening rate, but achieving 80% coverage, the 





Colorectal cancer (CRC) is the second leading cause of cancer deaths for both 
men and women in the United States (Siegel, Miller et al. 2017). There were an estimated 
135,430 new cases of and 50,260 deaths from CRC in 2017 (Siegel, Miller et al. 2017).  
Early detection of CRC, through routine screening, has been demonstrated to be effective 
in reducing the incidence of and mortality from this disease (Whitlock, Lin et al. 2008, 
Edwards, Ward et al. 2010, Siegel, Miller et al. 2017). The U.S. Preventive Services Task 
Force (USPSTF) strongly recommends screening for CRC beginning at the age of 50 
years and continuing until the age of 75 years for individuals at average risk, implying 
that increases in screening for CRC result in decreases of CRC mortality (Whitlock, Lin 
et al. 2008, Koretz 2016, US Preventive Services Task Force 2016).  
USPSTF recommends a  number of screening tests for use in detecting early-stage 
CRC and preventing incident cases, including 1) flexible sigmoidoscopy every 5 years, 2) 
FIT-DNA every 1 or 3 years, 3) fecal occult blood test or fecal immunochemical testing 
every year, 4) CT colonography every 5 years, 5) flexible sigmoidoscopy every 10 years 
plus FIT every year, and (6) colonoscopy every 10 years (US Preventive Services Task 




any type of screening test would be better than no screening at all (Atkin, Edwards et al. 
2010, Quintero, Castells et al. 2012, Patel and Kilgore 2015, US Preventive Services 
Task Force 2016). All the screening options are not equally attractive to all individuals; 
depending upon health history and preferences of individuals, the choices may differ 
significantly. However, from a clinical perspective, colonoscopy is the preferred method, 
because a colonoscopy allows doctors to examine the entire length of the colon and 
remove all cancers and precancerous polyps during a single procedure (Levin, Lieberman 
et al. 2008, Rex, Johnson et al. 2009, Wolf, Basch et al. 2016). Colonoscopy is also 
recommended as a follow-up when another CRC screening is positive. Moreover, 
colonoscopy has been validated in a randomized trial to have a mortality reduction 
benefit  (Zauber, Winawer et al. 2012, Patel and Kilgore 2015, Koretz 2016, US 
Preventive Services Task Force 2016).  
The mortality rate from CRC has decreased steadily since 1980 (Weir, Thompson 
et al. 2015, Siegel, Miller et al. 2017), which may be partially attributable to removal of 
pre-cancerous, adenomatous polyps at an early stage based on a diagnosis of CRC and 
widespread use of colonoscopies or other screening approaches (Cunningham, Atkin et 
al. 2010, Edwards, Ward et al. 2010, Lieberman 2010, Martin, Tully et al. 2017, Partin, 
Gravely et al. 2017). Nonetheless, the self-reported CRC screening rate in the National 
Health Interview Survey is at 58%, and the National Committee for Quality Assurance 
(NCQA) indicates that 60% of commercial and 69% of Medicare plan members aged 
received an appropriate CRC screening in 2016 (Paskett and Khuri 2015). Moreover, the 
Behavioral Risk Factor Surveillance System (BRFSS) indicates that around 65% of 




recommended by USPSTF, and around 60% of adults aged 50 to 75 years received a 
colonoscopy within the past 10 years (Joseph, King et al. 2012). These estimates are 
lower than the use of preventive interventions for other screening-amenable cancers, 
below the 80% coverage of the CRC screening target, and below the HP2020 target of 
71% (Swan, Breen et al. 2010, Karlitz, Oliphant et al. 2017). 
One potential barrier to CRC screening is the out-of-pocket financial costs 
associated with the screenings (Howard, Guy et al. 2014). The financial costs may 
significantly dampen patients’ willingness to adopt any preventive procedures, including 
any of the CRC screenings. This is especially true for colonoscopies, which usually 
involved a relatively high cost-sharing requirement prior to the ACA policy changes in 
2011 (Klabunde, Riley et al. 2004, Hamman and Kapinos 2015). Previous studies have 
shown that cost-sharing reduces preventive health care use, including the use of highly 
effective screening tests (Busch, Barry et al. 2006). One study found that waiving 
coinsurance for colonoscopies resulted in an 18% increase in screening (Khatami, Xuan 
et al. 2012). 
To address the negative consequences of financial barriers on the use of 
preventive services and to promote CRC screening, the Affordable Care Act (ACA) 
required all non-grandfathered private health plans to offer coverage of CRC screening 
without cost-sharing. Consistent with the ACA policy requirement, beginning January 1, 
2011, Medicare waived Part B deductibles for all colonoscopies and eliminated 
coinsurance for screening colonoscopies, though not for diagnostic ones (Howard, Guy et 
al. 2014, Hamman and Kapinos 2015). Therefore, Medicare beneficiaries may face 




colonoscopy, as these patients are billed a copay. Medicare beneficiaries are also 
responsible for Part B deductibles and coinsurance when a colonoscopy is performed as 
part of a two-step screening process after another CRC screening is positive (Howard, 
Guy et al. 2014). Nevertheless, the ACA policy change, in general, implies that the 
elderly insured population should see significant reductions in out-of-pocket expenses 
associated with colonoscopies.  
Research on the effects of cost-sharing reductions on utilization of preventive 
health care has received significant attention from researchers and policy makers, but 
surprisingly, only a few studies have assessed the effect of cost-sharing reduction on 
colonoscopies among the elderly insured population (including Medicare beneficiaries) 
following the implementation of the ACA (Hamman and Kapinos 2015, Cooper, Kou et 
al. 2016). The few studies that have examined this issue have used a very short time 
frame beginning with the implementation of the ACA, so they may have underestimated 
the effects of the ACA cost-sharing reduction. Furthermore, the results of these studies 
vary regarding the receipt of colonoscopies following the changes in coverage post-ACA, 
(Fedewa, Goodman et al. 2015, Hamman and Kapinos 2015, Cooper, Kou et al. 2016) 
and they have not been able to determine whether eliminating financial barriers might 
have helped socioeconomically vulnerable Medicare beneficiaries more than other 
groups. However, some of the socioeconomically vulnerable elderly may be enrolled in 
Medicaid, in that case, these individuals would have received colonoscopy without any 
out-of-pocket expenses in the pre-ACA years. This should not affect the results 




percentage of the elderly are enrolled in Medicaid (Medicaid only or dually eligible) 
(Grabowski 2012). 
To address these gaps in current research, this study aimed to examine the 
changes in colonoscopy use among the elderly insured population, including Medicare 
beneficiaries, following the implementation of the ACA policy for preventive services. 
Our hypothesis was that the elderly insured population have a greater likelihood of 
undergoing colonoscopies following the implementation of the ACA. We also wanted to 
determine whether the ACA policy changes have helped the socioeconomically 




This study used 2008-2016 BRFSS data, an annual, nationally representative 
survey implemented in the United States, the District of Columbia, Puerto Rico, Guam, 
the US Virgin Islands, American Samoa, and Palau. BRFSS uses random-digit telephone 
dialing methods to sample noninstitutionalized adults aged 18 years or older (Kirchhoff, 
Lyles et al. 2012, Schneider, Clark et al. 2012). The BRFSS is the largest ongoing public 
health survey in the world; in 2016, the number of completed interviews was 486,303. 
The objective of BRFSS is to collect uniform, state-specific data on health risk behaviors, 
chronic diseases and conditions, access to health care, and use of preventive health 





In 2008 the BRFSS began including questions about colonoscopies in even years. 
Therefore, this study used data from the years 2008, 2010, 2012, 2014, and 2016. 
Previous studies, using BRFSS from the years 2008, 2010, and 2012, have assessed the 
effect of cost-sharing reduction on colonoscopies among Medicare beneficiaries 
following the implementation of the ACA (Hamman and Kapinos 2015). One study used 
BRFSS to examine trends in breast and CRC screening in the U.S. by race, healthcare 
coverage, and socio-economic status before the Great Recession (2003-2005), during the 
recession (2007-2009), and at the beginning of the ACA period (2010-2012) (Wyatt, 
Pernenkil et al. 2017). Both these studies used a very short time frame beginning with the 
implementation of the ACA, so the studies may underestimate the effects of policy 
changes. The sample for this study consists of noninstitutionalized, insured elderly aged 
65 to 75 who participated in the survey. For our analyses, only those insured who were in 
the age group 65 to 75 years were included, bringing the sample size down to 446,981 
adults. We excluded individuals with missing values for variables of interest and those 
who refused to answer questions relevant in creating the main measures for the study. 
Thus, the analysis sample consisted of 349,899 participants (144,628 men and 205,271 





The outcome of interest in our study is the self-reported receipt of colonoscopies 




the individual answered “colonoscopy” to the question, “Was your last test a 
sigmoidoscopy or colonoscopy?”. To determine the years within which the colonoscopy 
was received, the responses to the following question was used: “How long has it been 
since you had your last sigmoidoscopy or colonoscopy?”. We defined our outcome 
variable as a dichotomous measure of whether an individual was up-to-date with the 
USPSTF screening recommendation. During our study period, the guideline 
recommended a colonoscopy be performed once over the previous 10 years. 
Based on previous studies (Benarroch-Gampel, Sheffield et al. 2012, Hamman 
and Kapinos 2015, Cooper, Kou et al. 2016), our analysis included demographic 
variables (age, sex, race and ethnicity, marital status, and region of residence) as possible 
covariates explaining adoption of colonoscopy. Age was classified into five categories: 
65-66; 67-68; 69-70; 71-72; and 73-75. Sex was classified into two categories: male and 
female. We incorporated race and ethnicity variable using the following discrete 
categories: non-Hispanic white, non-Hispanic Black, Hispanic, and other. Marital status 
was classified into two categories: married and other (divorced, widowed, separated, 
never married, and unmarried couple). Region of residence was classified into four broad 
geographic regions of the country based on FIPS codes: Northeast, Midwest, South, and 
West.  
We included two socioeconomic variables in the model as well (household 
income and educational attainment). Household income was reported using the following 
income classes: lower than $15,000; $15,000 to $25,000; $25,000 to $35,000; $35,000 to 




categories: did not graduate high school; graduated high school; attended college; and 
graduated from college. 
We pooled all five cycles of the survey into one large data set. The data set 
includes individual surveys conducted in the two years prior to the ACA policy change 
(2008 and 2010) and the three years after (2012, 2014, and 2016). Medicare, the 
predominant insurance provider among the elderly, waived deductibles for colonoscopies 
and eliminated coinsurance requirements effective January 1, 2011. To capture the effect 
of policy change on the receipt of colonoscopies, a policy-shift dummy variable was 
introduced into the model.  
We used geographic availability of gastroenterologists and degree of health 
awareness of surveyed individuals as possible covariates affecting the receipt of 
colonoscopies. The American Medical Association (AMA) Health Workforce Mapper 
reports availability of different specialists by state, and we used the reported number of 
professionally active gastroenterologists (GI) by state to calculate geographic availability 
of GIs per 1000 individuals in a given population. We reported the geographic 
availability of gastroenterologists as a quartile of gastroenterologist availability, meaning 
we divided the distribution of the variable into four groups having equal frequencies. The 
hypothesis was that receipt of colonoscopies will be affected by the availability of 
colonoscopy providers in an area. Previous studies have demonstrated that a greater 
provider supply has been associated with increased use of colonoscopies (Brouse, Wolf et 
al. 2008, Haas, Brawarsky et al. 2010, Benarroch-Gampel, Sheffield et al. 2012, Eberth, 




BRFSS does not have any direct measure of individual’s awareness of 
colonoscopy as a screening option or the importance assigned by individuals to 
preventive services which have little or no current benefits but improve future health. 
One of the concerns in estimating the effect of a policy change over the years is that 
individuals may become more aware of the importance of colonoscopies as well as other 
preventive services. Over the years, the awareness level may improve due to ongoing 
campaigns to popularize the use of colonoscopy as an effective approach in preventing 
CRC. If we assume that knowledge about all the preventive services are interrelated, 
“effective” use of one or more of preventive actions will also imply improvements in 
knowledge about the importance of colonoscopies. We decided to use two proxy 
measures for this purpose: participation in physical exercise and smoking status. 
Adoption of physical exercise reflects an individual’s willingness to accept a preventive 
activity to improve health in the future. Since participation in physical exercise represents 
an individual’s willingness to spend resources (time and energy) now for the betterment 
of health in the future, it may be considered an indirect measure of the degree of 
importance individuals assign to other preventive services like colonoscopies. Smoking 
status is a more complex proxy measure, probably reflecting the individual’s long-term 
perspective on future health status and the implicit time discount rate. Smokers are likely 
to discount future years at a much higher rate than non-smokers and former smokers. 
Those with lower time preference rate (lower discount rate) are more likely to adopt 
preventive interventions and screenings (Axon, Bradford et al. 2009, Bradford 2010). We 




within the last 30 days and those who did not. Smoking status was categorized into three 
groups: current smoker, former smoker, and never smoked. 
 
Statistical Analyses 
Descriptive statistics were used to summarize participant characteristics and to 
report the number and percentage of participants for each of the variables. We also 
reported the percentage of respondents who had a colonoscopy in the previous 10 years 
by pre- and post-ACA policy change. We reported the percentage change instead of 
actual change as the percentage change method more precisely depicts the changes in 
data over a period of time. Bivariate and multivariate logistic models were used to 
estimate the effects of the policy-shift on the receipt of colonoscopies among insured 
elderly aged 65 to 75 years. The multivariate models adjusted the outcome variable for 
demographic characteristics (age, sex, race/ethnicity, marital status, and region of 
residence), socioeconomic status (household income and educational attainment), 
geographic availability of gastroenterologists, health awareness proxies (exercise and 
smoking status), and the policy change shifter variable. Sampling weights were used to 
derive national estimates for the sample included in this analysis. All statistical analyses 
were performed using SAS version 9.4 (SAS Inc., Cary, NC, USA). 
 
RESULTS 
The data set had 349,899 adults aged 65 to 75 years (Table 4.1). Non-Hispanic 




blacks (9.2%), Hispanics (7.1%), and other (5.1%). The majority of participants were 
female (58.7%), married (54.8%), had exercised in the last 30 days (72.7%), and had 
received a colonoscopy within the last 10 years (67.5%). Figure 4.2 presented the 
percentage of participants who received a colonoscopy in the last 10 years from 2008 to 
2016. During the period from 2008 to 2016, 236,275 participants received a 
recommended colonoscopy (67.2%). Colonoscopy use increased from 61.2% in 2008 to 
69.9% in 2016 (p<.0001). 
Table 4.2 showed colonoscopy use before and after the implementation of the 
ACA. Compared with Non-Hispanic blacks, Hispanics, and other participants, Non-
Hispanic white participants were more likely to have received a colonoscopy in the last 
10 years (p<.0001). Compared with individuals living in the South, Midwest, and West 
regions, individuals living in the Northeast were more likely to receive a recommended 
colonoscopy (p<.0001). Compared with participants who had a household income under 
$15,000, participants with a household income greater than $50,000 were more likely to 
receive the recommended colonoscopy (p<.0001). We found that the receipt of 
colonoscopies increased after implementation of the ACA, and that increases were largest 
among the socioeconomically vulnerable elderly (Table 4.2). Overall, the receipt of 
colonoscopies increased from 63.5% in pre-ACA years to 69.2% in post-ACA years 
(p<.0001) (Figure 4.3). The receipt of colonoscopies increased by 15.1% among the 
elderly insured with household incomes under $15,000, but only by 6.5% among those 
with household incomes greater than $50,000. The receipt of colonoscopies increased by 
15.9% among elderly insured who did not graduate high school, but by 7.3% among 




income and individual educational attainment indicated larger gains among the 
socioeconomically vulnerable elderly (Table 4.2). 
Figure 4.4 (a) and (b) showed colonoscopy use before and after the 
implementation of the ACA by household income and educational attainment. We found 
that the receipt of colonoscopies increased after the implementation of the ACA for all 
household income groups, and the increase was the largest among individuals with less 
than $15,000 household income. In terms of educational attainment, receipt of 
colonoscopies increased for all groups, but the increases were largest among individuals 
who did not graduate high school. 
Table 4.3 reports the results of the multivariate analysis of factors associated with 
colonoscopy use over the previous 10 years. Increased use of colonoscopy was associated 
with older age, being female, exercise status, and smoking status. After controlling for 
demographic characteristics, socioeconomic status and other relevant variables, the 
policy shift variable was statistically significant, implying that colonoscopy use increased 
among the elderly insured after the implementation of the ACA (OR, 1.15; 95% 
confidence limit [CI], 1.08-1.22), given various socioeconomic, demographic and other 
relevant covariates. Female participants were 1.19 times more likely to receive a 
recommended colonoscopy than male participants (OR=1.19, CI, 1.15-1.22). Non-
Hispanic blacks were significantly more likely (OR=1.16, CI, 1.10-1.23) and Hispanics 
were significantly less likely (OR=0.78, CI, 0.72-0.84) to receive recommended 
colonoscopies, compared with non-Hispanic whites. 
We found a strong positive association between being married and the probability 




recommended colonoscopy compared to unmarried participants. Individuals living in the 
highest quartile of gastroenterologist availability states were significantly more likely 
(OR=1.15, CI, 1.10-1.21) to receive recommended colonoscopies compared with 
individuals living in the lowest quartile of gastroenterologist availability states. 
Individuals who had exercised in the past 30 days were 1.23 times more likely to have 
received a recommended colonoscopy compared with individuals who hadn’t exercised 
in the past 30 days (OR=1.23, CI, 1.19-1.27). Former smokers (OR=1.71, CI, 1.63-1.80) 
and those who never smoked (OR=1.50, CI, 1.43-1.57) were significantly more likely to 
have received a recommended colonoscopy compared with current smokers (Table 4.3). 
Individuals with a household income greater than $50,000 were 2.10 times more 
likely to have received a recommended colonoscopy compared with individuals whose 
household income was less than $15,000 (OR=2.10, CI, 1.97-2.24). Individuals who 
graduated from college were 1.53 times more likely to have received a recommended 
colonoscopy compared with individuals who did not graduate high school (OR=1.53, CI, 
1.44-1.63). We tested interaction terms combining policy shift variable with 
race/ethnicity, educational attainment, and household income; but none of the interaction 
terms were statistically significant. This implies that the effect of race/ethnicity, 
education, and income on colonoscopy adoption did not change in the post-ACA 









Analysis of BRFSS data indicates that the receipt of colonoscopies among the 
elderly insured increased from 63.5% in pre-ACA years to 69.2% in post-ACA years. 
Elderly insured in the age group 65 to 75 years (most of whom are Medicare 
beneficiaries) are 1.15 times more likely to be up-to-date with colonoscopy screening 
after the policy change when compared to their pre-ACA status, after controlling for a 
number of individual and geographic factors. Although the analysis could not incorporate 
out-of-pocket expenses directly into the model due to lack of data, it is likely that the 
increase in colonoscopy uptake observed in the post-ACA years was due to the reduction 
in cost-sharing. Increased coverage of colonoscopy appears to be more pronounced 
among elderly insured who are less educated and in lower household income groups.  
Consistent with earlier research findings (Hamman and Kapinos 2015), our results 
confirmed that there was a statistically significant increase in colonoscopy use among 
elderly beneficiaries aged 65 to 75 years after the implementation of the ACA. The 
results also correspond with prior literature showing a positive association between cost-
sharing reduction and utilization of recommended preventive services (Goodwin and 
Anderson 2012, Han, Robin Yabroff et al. 2015, Cooper, Kou et al. 2016, Misra, Lloyd et 
al. 2018). However, even with higher coverage of colonoscopies after ACA 
implementation, approximately half of the elderly insured in the age group 65-75 years 
with household income less than $15,000 received a recommended colonoscopy. 
Moreover, 55.5% of the elderly insured aged 65-75 years without a high school diploma 
received a colonoscopy in the previous 10 years in post-ACA years. Therefore, even after 




of colonoscopy remains suboptimal and much lower than the 80% target by 2018. It is 
important to identify specific approaches to encourage socioeconomically disadvantaged 
elderly to seek colonoscopies in order to achieve a higher rate of progress in achieving 
the target 80%, even though increases in colonoscopy uptake were the largest among the 
lower income and education groups in post-ACA levels compared to pre-ACA levels. 
Nonetheless, we found a significant increase in colonoscopy use among elderly 
insured with lower socioeconomic status after implementation of the ACA. This may, in 
part, reflect the effect of removal of out-of-pocket costs, since financial barriers are found 
to reduce coverage of cancer screening (Doubeni, Laiyemo et al. 2010), and 
colonoscopies are expensive (Pyenson, Scammell et al. 2014). It is also possible that the 
increase in the receipt of colonoscopies among lower socioeconomic groups may reflect 
the continuation of increasing trends that have been observed nationwide, as well as the 
proliferation of private health plans (Klabunde, Cronin et al. 2011, Shapiro, Klabunde et 
al. 2012, Wernli, Hubbard et al. 2014). It is clear that the increase was universal across 
socioeconomic status and not limited to subjects with lower income and lower levels of 
education. However, despite the improvements in colonoscopy uptake over the years, the 
poorest and the most socially disadvantaged groups represent the highest potential for 
improvement, given their relatively low rates of colonoscopy use. For achieving the 
target screening rate, additional interventions should be considered in addition to the 
lowering of barriers to access. The ACA’s reduction of financial barriers has improved 
adherence to CRC screening, but other non-medical costs should be considered more 




There are several barriers to the receipt of colonoscopies other than cost, 
including perceived loss of utility associated with bowel preparation prior to the test, 
logistical challenges, not receiving a physician’s recommendation for CRC screening, 
and believing that CRC screening is not important or necessary (McAlearney, Reeves et 
al. 2005, Guessous, Dash et al. 2010, Jones, Devers et al. 2010). Patients’ perception of 
insurance coverage has been shown to deter cancer screening use (McAlearney, Reeves 
et al. 2005), which indicates the need for improved awareness of the ACA’s cost-sharing 
reduction provision among the elderly insured population. The Medicare program needs 
to ensure that all Medicare beneficiaries are aware of the new policy, that part B do not 
require any deductible or coinsurance for screening colonoscopies. Eliminating the cost-
sharing for therapeutic colonoscopies could be the next policy reform to be considered in 
improving adherence to colorectal cancer screening even further (Hamman and Kapinos 
2015). 
Previous studies found divergent results of post-ACA changes in CRC screenings 
among the elderly and Medicare beneficiaries (Fedewa, Goodman et al. 2015, Hamman 
and Kapinos 2015, Han, Robin Yabroff et al. 2015, Cooper, Kou et al. 2016). Some 
studies found an increase in the receipt of CRC screening (Fedewa, Goodman et al. 2015, 
Hamman and Kapinos 2015), while others found no change in the use of any cancer 
screening procedure (Han, Robin Yabroff et al. 2015, Cooper, Kou et al. 2016). Unlike 
these studies, our study was able to use a longer time-frame to examine the effect of ACA 
policy changes on colonoscopy use. With this longer time lapse since implementation of 
the ACA, we found a significant effect of policy change when many other potential 




availability of health care providers in the area as a control factor, something none of the 
earlier analyses had considered. The supply-side variable indicates that the availability of 
GIs in the geographic area affects the likelihood of receiving a colonoscopy within the 
recommended time frame.   
This study has several limitations. First, the BRFSS is based on self-reports, 
which may be subject to recall bias. True screening rates are more likely to be less than 
50% for adults aged 50 years or older (Paskett and Khuri 2015). Therefore, one challenge 
is establishing the accurate rate of colonoscopy receipt. The BRFSS did not carry out 
cross-checking of reported colonoscopy with individuals’ medical records (Ferrante, 
Ohman-Strickland et al. 2008, Schenck, Klabunde et al. 2008). Second, there is also a 
possibility of selection bias in this type of survey because less healthy patients may not 
be included in the sample. Third, the BRFSS does not include information about actual 
out-of-pocket expenditures or other non-medical expenses associated with the screening, 
such as opportunity cost associated with time or difficulty in scheduling colonoscopies 
(Dong, Kalmaz et al. 2011, Petryszyn, Kempinski et al. 2014). Fourth, this study could 
not distinguish between screening and therapeutic colonoscopies and whether or not the 
ACA policy itself changed the providers’ behavior in terms of recommending screening 
or therapeutic colonoscopies. Fifth, gastroenterologists are not only providers of 
colonoscopy and there are regional variations (Benarroch-Gampel, Sheffield et al. 2012, 
Joseph, Meester et al. 2016). Sixth, there is also the possibility of historical threats to 
validity (e.g. increasing awareness over time and social norms in support of CRC). 
Seventh, this study could not assess awareness of CRC. Finally, in 2011 BRFSS changed 




phone respondents are likely to be different from others in terms of age and risk of CRC. 
Therefore, this additional approach of selecting respondents may have affected the 
sample of 2011 in comparison with samples from the pre-2011 period.  
In summary, our results confirmed that there was a statistically significant 
increase in colonoscopy use among the elderly insured aged 65 to 75 years after the 
implementation of the ACA. Although Medicare waived Part B deductibles for all 
colonoscopies and eliminated coinsurance for screening colonoscopies, individuals are 
still subject to out-of-pocket medical expenses for therapeutic colonoscopies (Hamman 
and Kapinos 2015). Our results indicate that the ACA’s reduction of financial barriers has 
improved usage of CRC screening and further improvements will be possible if the costs 
associated with therapeutic colonoscopies can be reduced or eliminated. Policy makers 
should also try to understand other related expenses, both medical and non-medical costs, 
associated with the receipt of colonoscopies by the elderly (Dong, Kalmaz et al. 2011, 
Petryszyn, Kempinski et al. 2014). Reducing these costs will also help achieve the 
national target rate of colonoscopy use. Moreover, our results indicate that greater 
provider supply has been associated with increased use of colonoscopies. An increased 
supply of providers may have little beneficial effect on race and ethnic disparities in the 
receipt of colonoscopies or on geographic disparities in the receipt of colonoscopies 
(Benarroch-Gampel, Sheffield et al. 2012, Eberth, Josey et al. 2017). Interventions should 
focus on improving screening in populations living in rural areas and among minorities. 
A recent study reported that the estimated colonoscopist capacity was sufficient to screen 
80% of the eligible U.S. population (Joseph, Meester et al. 2016). However, 




time than that which the average physician spends on such a procedure (Vicari 2010). If a 
particular area has a short supply of gastroenterologists, short-run alternatives may be 
possible, such as training primary care providers to conduct colonoscopies (Selby, 
Cornuz et al. 2016).   
The results of this study indicate that the use of colonoscopies increased among 
the elderly insured after the implementation of the ACA cost-sharing rule for preventive 
services. Reduction of financial barriers has been effective in improving CRC screening, 
and further reduction in financial barriers is likely to improve uptake of CRC screening in 
the future. The financial barriers are not only due to medical care costs but also due to 
other non-medical expenses, and policy makers should consider how to improve access to 
preventive services by considering all the potential barriers to access. In general, 
lowering out-of-pocket expenses for colonoscopies has improved receipt of 
colonoscopies by all elderly groups; but the increase in coverage was higher for poorer 
individuals and individuals with low educational attainment. Therefore, reduction in out-
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Table 4.1. Characteristics of Survey Participants Aged 65 to 75 Years: Behavioral Risk Factor Surveillance System (BRFSS), 2008-2016 
Characteristic 
 Total   Pre-ACA (2008, 2010)  Post-ACA (2012, 2014, 2016) 
 N   Weighted N   %   N   Weighted N   %   N   Weighted N   %  
Total 349,899 20,760,005 100.0 125,577 7,292,561 100.0 224,322 13,467,444 100.0 
Age (years)           
65-66     78,424        4,778,975      23.0      27,686        1,657,607      22.7      50,738        3,121,369      23.2  
67-68     72,261        4,293,712      20.7      25,928        1,492,646      20.5      46,333        2,801,066      20.8  
69-70     65,746        3,853,545      18.6      22,953        1,308,456      17.9      42,793        2,545,089      18.9  
71-72     56,989        3,307,273      15.9      20,739        1,187,668      16.3      36,250        2,119,606      15.7  
73-75     76,479        4,526,499      21.8      28,271        1,646,184      22.6      48,208        2,880,315      21.4  
 
Sex 
         
Male   144,628      10,041,253      48.4      49,856        3,498,723      48.0      94,772        6,542,530      48.6  
Female   205,271      10,718,752      51.6      75,721        3,793,838      52.0    129,550        6,924,915      51.4  
 
Race/ethnicity 
         
Non-Hispanic White   300,176      16,335,132      78.7    107,573        5,787,662      79.4    192,603      10,547,470      78.3  
Non-Hispanic Black     23,541        1,900,058        9.2        8,262           625,413        8.6      15,279        1,274,645        9.5  
Hispanic     11,393        1,464,786        7.1        4,523           515,157        7.1        6,870           949,629        7.1  
Other     14,789        1,060,030        5.1        5,219           364,328        5.0        9,570           695,702        5.2  
 
Married  
  191,812      13,062,607      62.9      67,832        4,791,316      65.7    123,980        8,271,291      61.4  
 
Region of Residence 
         
Northeast     63,156        3,721,267      17.9      21,448        1,333,058      18.3      41,708        2,388,209      17.7  
Midwest     83,992        4,610,164      22.2      27,263        1,611,787      22.1      56,729        2,998,377      22.3  
South   117,730        7,807,516      37.6      45,098        2,740,775      37.6      72,632        5,066,741      37.6  
West     85,021        4,621,059      22.3      31,768        1,606,941      22.0      53,253        3,014,117      22.4  
 
Household income 
         
Less than $15,000     37,975        2,132,736      10.3      16,145           799,267      11.0      21,830        1,333,470        9.9  
$15,000 to less than $25,000     71,719        3,999,888      19.3      28,776        1,493,125      20.5      42,943        2,506,764      18.6  









$35,000 to less than $50,000     61,885        3,648,907      17.6      22,442        1,296,287      17.8      39,443        2,352,620      17.5  
$50,000 or more   127,275        8,081,747      38.9      38,035        2,598,784      35.6      89,240        5,482,963      40.7  
Education          
Did not graduate high school     28,997        2,565,191      12.4      13,251           834,555      11.4      15,746        1,730,636      12.9  
Graduated High School   107,851        6,286,535      30.3      43,068        2,350,414      32.2      64,783        3,936,121      29.2  
Attended College     92,346        5,878,894      28.3      31,705        1,770,625      24.3      60,641        4,108,269      30.5  
Graduated from College   120,705        6,029,384      29.0      37,553        2,336,966      32.0      83,152        3,692,418      27.4  
 
Colonoscopy within 10 years 
         
No   113,624        6,815,019      32.8      46,619        2,660,497      36.5      67,005        4,154,522      30.8  
Yes   236,275      13,944,986      67.2      78,958        4,632,063      63.5    157,317        9,312,922      69.2  
 
Quartile of Gastroenterologist Availability* 
       
Q1      59,323        1,810,049        8.7      20,757           636,937        8.7      38,566        1,173,112        8.7  
Q2   110,334        5,347,096      25.8      39,196        1,864,253      25.6      71,138        3,482,844      25.9  
Q3     86,369        7,348,162      35.4      33,101        2,566,325      35.2      53,268        4,781,836      35.5  
Q4     93,873        6,254,698      30.1      32,523        2,225,046      30.5      61,350        4,029,653      29.9  
 
Exercise in past 30 days 
         
No     95,614        5,765,920      27.8      36,007        2,027,556      27.8      59,607        3,738,364      27.8  
Yes   254,285      14,994,085      72.2      89,570        5,265,004      72.2    164,715        9,729,081      72.2  
 
Smoking Status 
         
Current smoker     40,547        2,331,537      11.2      15,127           808,134      11.1      25,420        1,523,403      11.3  
Former smoker   149,275        9,133,039      44.0      55,012        3,271,931      44.9      94,263        5,861,108      43.5  
Never smoked   160,077        9,295,429      44.8      55,438        3,212,495      44.1    104,639        6,082,934      45.2  
Note. *Gastroenterologist availability quartiles are determined by the number of gastroenterologists per 1,000 (2010) in the respondent’s state. The American 
Medical Association (AMA) Health Workforce Mapper reports the availability of different specialists by state, and we have used the reported number of 




Table 4.2. Colonoscopy Use Before and After Implementation of The Affordable Care Act Policy 
Change: Behavioral Risk Factor Surveillance System (BRFSS), 2008-2016 
Variables 
 Colonoscopy within the past 10 years  
 Pre ACA   Post ACA   Differences  
 %   %   % Change  
Total 63.5 69.2 8.9 
Age (years)    
65-66 62.2 67.3 8.2 
67-68 63.5 69.9 10.0 
69-70 64.2 69.8 8.7 
71-72 63.8 70.1 9.8 
73-75 64.1 69.2 7.9 
Sex    
Male 63.7 68.7 7.9 
Female 63.4 69.6 9.8 
Race/ethnicity    
Non-Hispanic White 65.5 70.9 8.2 
Non-Hispanic Black 61.4 70.0 14.0 
Hispanic 50.0 56.2 12.5 
Other 54.8 59.2 8.1 
Married     
Yes 66.7 72.4 8.6 
No 57.5 64.0 11.4 
Region of Residence    
Northeast 67.3 71.9 6.8 
Midwest 64.7 70.2 8.4 
South 63.9 70.2 9.8 
West 58.5 64.2 9.8 
Household income    
Less than $15,000 45.5 52.4 15.1 
$15,000 to less than $25,000 55.7 61.1 9.6 
$25,000 to less than $35,000 63.4 67.1 5.9 
$35,000 to less than $50,000 66.4 71.0 6.9 
$50,000 or more 72.1 76.8 6.5 
Education    
Did not graduate high school 47.9 55.5 15.9 
Graduated High School 61.2 66.8 9.3 
Attended College 64.4 71.0 10.3 
Graduated from College 70.8 76.0 7.3 
Quartile of Gastroenterologist Availability    
Q1  59.5 66.5 11.8 
Q2 64.2 70.4 9.6 
Q3 61.2 66.9 9.3 
Q4 66.7 71.5 7.2 
Exercise in past 30 days    
No 57.0 63.0 10.5 
Yes 66.0 71.5 8.3 
Smoking Status    
Current smoker 49.0 55.7 13.8 
Former smoker 66.8 71.8 7.6 




Table 4.3. Multivariate Analysis of Factors Associated with Colonoscopy Use: Behavioral Risk 
Factor Surveillance System (BRFSS), 2008-2016 
  
 Colonoscopy within the past 10 years  
 OR   (95% CI)  
Policy shift 1.15 1.08 1.22 
Age (years)    
65-66 1.00   
67-68 1.11 1.06 1.16 
69-70 1.15 1.09 1.20 
71-72 1.16 1.11 1.22 
73-75 1.16 1.11 1.21 
Sex    
Male 1.00   
Female 1.19 1.15 1.22 
Race/ethnicity    
Non-Hispanic White 1.00   
Non-Hispanic Black 1.16 1.10 1.23 
Hispanic 0.78 0.72 0.84 
Other 0.70 0.64 0.77 
Married     
Yes 1.00   
No 0.84 0.82 0.87 
Region of Residence    
Northeast 1.00   
Midwest 0.98 0.92 1.03 
South 0.98 0.93 1.03 
West 0.74 0.70 0.79 
Household income    
Less than $15,000 1.00   
$15,000 to less than $25,000 1.25 1.18 1.33 
$25,000 to less than $35,000 1.53 1.44 1.63 
$35,000 to less than $50,000 1.69 1.59 1.80 
$50,000 or more 2.10 1.97 2.24 
Education    
Did not graduate high school 1.00   
Graduated High School 1.24 1.17 1.31 
Attended College 1.37 1.29 1.45 
Graduated from College 1.53 1.44 1.63 
Quartile of Gastroenterologist Availability   
Q1  1.00   
Q2 1.15 1.11 1.19 
Q3 1.06 1.02 1.10 
Q4 1.15 1.10 1.21 
Exercise in past 30 days    
No 1.00   
Yes 1.23 1.19 1.27 
Smoking Status    
Current smoker 1.00   
Former smoker 1.71 1.63 1.80 
Never smoked 1.50 1.43 1.57 
Years 1.03 1.02 1.04 















Figure 4.2. Percentage of participants who received a colonoscopy in the previous 10 years 
from 2008 to 2016 















































Figure 4.3. Changes in receipt of colonoscopy among insured Elderly aged 65 to 75 years.  
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Figure 4.4 (a). Colonoscopy use before and after implementation of the ACA by household 





Figure 4.4 (b). Colonoscopy use before and after implementation of the ACA by 



























































































































4.2 Manuscript 2 
 
DECOMPOSING SOCIO-ECONOMIC DISPARITY IN THE USE OF COLONOSCOPY AMONG 
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Background: Increases in CRC screening rates have been demonstrably effective in 
reducing the incidence of and mortality from this disease, but the use of CRC screening 
remains lower than the use of preventive interventions for other screening-amenable 
cancers; and CRC screening rates are below the 80% NCCRT target coverage and the 
70% HP2020 target coverage. 
Objective: The objectives of this paper are to examine how income-related disparities in 
CRC screening in the United States have changed over the past decade, especially in the 
years prior to and after the implementation of Affordable Care Act (ACA) and to quantify 
the contributions of different factors in explaining the disparity in the use of 
colonoscopies among elderly population with health insurance coverage.  
Methods: Five cycles (2008, 2010, 2012, 2014, and 2016) of Behavioral Risk Factor 
Surveillance System (BRFSS) data were utilized. To examine income-related disparities 
in the use of CRC, individuals aged 65 to 75 were included, and the Concentration Index 
(CI) was calculated before and after the implementation of ACA. To identify and 
quantify the contribution of different factor, a decomposition analysis of CI was 
conducted. 
Results: CIs decreased from 0.1935 in pre-ACA years to 0.1813 in the post-ACA years 
among the elderly, indicating that the disparity in the use of colonoscopy was relatively 
low and the disparity index declined after the implementation of ACA. Decomposition 




educational level, higher level of income and educational attainment were major 
contributors to the observed disparities in colonoscopy use.   
Conclusions: Our findings indicate that the ACA’s removal of financial barriers may 
have contributed towards the reduction in disparity of colonoscopy use. It appears that 
financial aspects will not be adequate for further reduction in disparity. More direct 
interventions, e.g., improved knowledge, better access and lower indirect cost will be 
helpful in improving screening among low income and low educational attainment 
households.  
 




The incidence of and mortality rates from colorectal cancer (CRC) have been 
steadily decreasing in the United States (US) since the 1980s (Weir, Thompson et al. 
2015, Siegel, Miller et al. 2017). This may, in part, be due to substantial advances in 
screening, a general agreement among health care providers and policy-makers in 
screening recommendations and evidence of cost-effectiveness of screening 
(Cunningham, Atkin et al. 2010, Edwards, Ward et al. 2010, Lieberman 2010, US 
Preventive Services Task Force 2016, Martin, Tully et al. 2017, Partin, Gravely et al. 
2017). Increases in screening have been demonstrably effective in reducing the incidence 




these rates (Whitlock, Lin et al. 2008, Edwards, Ward et al. 2010, Siegel, Miller et al. 
2017).  
The U.S. Preventive Services Task Force (USPSTF) strongly recommends that for 
individuals at average risk, CRC screening should begin at age 50 and continue until age 
75. The recommendation is guided by the evidence that screening for CRC generates 
substantial net benefits for the target group (Whitlock, Lin et al. 2008, Koretz 2016, US 
Preventive Services Task Force 2016). The USPSTF recommends screening by any of 
the accepted methods, as any sort of screening test is better than no screening at all 
(Atkin, Edwards et al. 2010, Quintero, Castells et al. 2012, Patel and Kilgore 2015). Not 
all screening options, however, are equally attractive to all individuals; depending upon 
individuals’ health history and preferences, the choices may vary significantly. From a 
clinical perspective, colonoscopy is the most preferred method, because an effective 
colonoscopy allows doctors to examine the entire length of the colon and to remove all 
cancers and precancerous polyps, if found, in the same procedure (Levin, Lieberman et 
al. 2008, Rex, Johnson et al. 2009, Wolf, Basch et al. 2016). Colonoscopy is also 
recommended as a follow-up when another CRC screening is positive. Moreover, 
colonoscopy has been validated in a randomized trial as providing a clear mortality 
reduction benefit (Zauber, Winawer et al. 2012, Patel and Kilgore 2015, Koretz 2016, US 
Preventive Services Task Force 2016).  
Nonetheless, the self-reported CRC screening rate in the 2013 National Health 
Interview Survey was only 58%, and the National Committee for Quality Assurance 
(NCQA) indicates that 60% of commercial insurance buyers and 68.5% of Medicare plan 




Behavioral Risk Factor Surveillance System (BRFSS) data indicate that around 65% of 
adults aged 50 to 75 have undergone one of the colorectal screening tests recommended 
by USPSTF, and around 60% of adults aged 50 to 75 have received a colonoscopy within 
the past 10 years (Joseph, King et al. 2012).  
Previous studies have identified the determinants of CRC screening disparities, 
and the majority of studies have found that individual socioeconomic status (SES) is an 
important determinant (Courtney, Paul et al. 2013, Fedewa, Ma et al. 2015, Meyer, Allard 
et al. 2016, White, Thompson et al. 2017). Growing evidence indicates that screening 
colonoscopy is most likely among individuals with higher income, even among insured 
population (Benarroch-Gampel, Sheffield et al. 2012, Centers for Disease Control and 
Prevention 2013, Solbak, Xu et al. 2018). Healthy People 2020 (HP2020) has four 
overarching goals: to attain high-quality, longer lives free of preventable disease, to 
create social and physical environments, to promote quality of life, healthy development, 
and healthy behaviors, and to eliminate disparities (White, Thompson et al. 2017). 
Understanding the temporal trends in disparities as well as the factors explaining the 
disparities are important in formulating policy options to reduce disparity in the use of 
screening tests like colonoscopy (White, Thompson et al. 2017). To increase CRC 
screening rates and reduce the disparities in screening, beginning January 1, 2011, 
Medicare waived Part B deductibles for all colonoscopies and eliminated coinsurance for 
screening colonoscopies (Howard, Guy et al. 2014, Hamman and Kapinos 2015). 
Individuals with other type of insurance coverage also saw their out-of-pocket costs 




From a policy perspective, identifying the factors or characteristics that contribute 
most to the observed disparities in colonoscopy is important in designing effective 
programs and prioritizing interventions. Decomposing income-related disparities in 
colonoscopy use can help uncover factors that are potentially modifiable. Therefore, the 
purpose of this study is to examine changes in income-related disparities in colonoscopy 
use in pre-ACA and post-ACA years and to decompose the disparities into important 





This study used 2008-2016 BRFSS data, an annual, nationally representative 
survey implemented in the United States, the District of Columbia, Puerto Rico, Guam, 
the US Virgin Islands, American Samoa, and Palau. BRFSS uses random-digit telephone 
dialing methods to sample noninstitutionalized adults aged 18 years or older (Kirchhoff, 
Lyles et al. 2012, Schneider, Clark et al. 2012). The BRFSS is the largest ongoing public 
health survey in the world; in 2016, the number of completed interviews was 486,303. 
The objective of BRFSS is to collect uniform, state-specific data on health risk behaviors, 
chronic diseases and conditions, access to health care, and use of preventive health 




In 2008 the BRFSS began including questions about colonoscopies in even years. 
Therefore, this study used data from the years 2008, 2010, 2012, 2014, and 2016. 
Previous studies, using BRFSS from the years 2008, 2010, and 2012, have assessed the 
effect of cost-sharing reduction on colonoscopies among Medicare beneficiaries 
following the implementation of the ACA (Hamman and Kapinos 2015). One study used 
BRFSS to examine trends in breast and CRC screening in the U.S. by race, healthcare 
coverage, and socio-economic status before the Great Recession (2003-2005), during the 
recession (2007-2009), and at the beginning of the ACA period (2010-2012) (Wyatt, 
Pernenkil et al. 2017). These studies used a very short time frame beginning with the 
implementation of the ACA, so the studies may underestimate the effects of policy 
changes. The sample for this study consists of noninstitutionalized, insured elderly aged 
65 to 75 who participated in the survey from the years 2008, 2010, 2012, 2014, and 2016. 
For our analyses, only those insured who were in the age group 65 to 75 years were 
included, bringing the sample size down to 446,981 adults. We excluded individuals with 
missing values for variables of interest and those who refused to answer questions 
relevant in creating the main measures for the study. Thus, the analysis sample consisted 
of 349,899 participants (144,628 men and 205,271 women) aged 65 to 75 years.  
 
Definition of the Measures Used 
The variable of interest for the study is the self-reported receipt of a colonoscopy 
in the previous 10 years. A respondent is considered to have received a colonoscopy if 




sigmoidoscopy or colonoscopy?”. To determine the years within which the colonoscopy 
was received, the responses to the follow-up question were used: “how long has it been 
since you had your last sigmoidoscopy or colonoscopy?”. We defined our outcome 
variable as a dichotomous measure of whether an individual was up-to-date with the 
USPSTF screening recommendation. During our study period, the guidelines 
recommended having a colonoscopy once every 10 years. 
 The literature has identified several sets of variables to explain variations in 
colonoscopy use (Benarroch-Gampel, Sheffield et al. 2012, Centers for Disease Control 
and Prevention 2013, Courtney, Paul et al. 2013, Howard, Guy et al. 2014, Ramdass, 
Petraro et al. 2014, Hamman and Kapinos 2015, Partin, Gravely et al. 2016, Grzywacz, 
Hussain et al. 2017). We included age, sex, race and ethnicity. Age was categorized into 
five groups: 65-66, 67-68, 69-70, 71-72, and 73-75. Sex was classified into two 
categories: male and female. Participants’ race and ethnicity was categorized into four 
groups: non-Hispanic white, non-Hispanic Black, Hispanic, and other. We dichotomized 
marital status as married or not married. We described geographic characteristics by 
census region (Northeast, Midwest, South, and West). Based on previous studies 
(Benarroch-Gampel, Sheffield et al. 2012, Hamman and Kapinos 2015, Solmi, Von 
Wagner et al. 2015, Cooper, Kou et al. 2016), our analysis included household income 
and educational attainment. We used a categorical measure of annual household income 
with the following categories: lower than $10,000; $10,000 to $14,999; $15,000 to 
$19,999; $20,000 to $24,999; $25,000 to $34,999; $35,000 to $49,999; $50,000 to 
$74,999; and $75,000 or more. Educational attainment was classified into four categories: 




from college. Racial and ethnic disparities in CRC screening had already been broadly 
documented, and most studies found that individuals belonging to ethnic minorities were 
less likely to adhere to screening guidelines; lower socio-economic status (indicating 
dimensions such as income, education, and employment status) among ethnic minority 
groups is considered the most likely explanation for this finding (Shih, Zhao et al. 2006, 
Benarroch-Gampel, Sheffield et al. 2012, Burnett-Hartman, Mehta et al. 2016, Hong, 
Tauscher et al. 2017). In addition, lower educational attainment is associated with lower 
adherence to CRC screening guidelines (Gimeno Garcia 2012, Kobayashi, Wardle et al. 
2014).   
The final data set generated for this analysis includes two years of information 
prior to the implementation of ACA (2008 and 2010) and three years of information 
following the implementation of ACA (2012, 2014, and 2016). Since a large majority of 
this group is covered by Medicare, the policy changes adopted by Medicare should have 
significant impact on the use of colonoscopy. For controlling the time trade-off rates of 
individuals and willingness to spend resources for improving future health status, we 
incorporated two variables in the analysis: whether the individual exercised or not within 





The concentration index has demonstrated its usefulness as a tool in measuring 




utilization of various medical care services or outcomes. To estimate the concentration 
index, one variable must be used as the main metric to rank households on the basis of 
levels of living or socioeconomic status. We can use household income as the measure to 
calculate the concentration index in the use of colonoscopies. The standard concentration 









where 𝑛 is the sample size, 𝑦𝑖 is healthcare utilization of individual 𝑖, μ is its mean and 
𝑅𝑖 =  
𝑖
𝑁
  is the fractional rank of individual 𝑖 in household income distribution. For a 
given μ > 0, the maximum of the concentration index is when the poorest 𝑖 individuals 
have a value of 𝑦𝑖 equal to zero and the richest 𝑛 −  𝑖  individuals have a value of 𝑦𝑖 
equal to 1. In this case, the value of CI will be maximum at +14. If the poorest person 
uses CRC screening and not anyone else, the CI will have the value of -1. If the richest 
person uses CRC screening and not anyone else, the CI will have the value of +1. If CI 
equals zero, then there is no income-related disparity in the distribution of CRC 
screening. As this analysis have used a binary response indicating whether or not a 
insured elderly had a recommended colonoscopy, normalized concentration index 
employing the Wagstaff decomposition method was applied (Wagstaff 2005). Standard 
                                                          
4 𝐶𝐼 = 2
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errors for the normalized index correct for both autocorrelation and heteroscedasticity 






We first compared the difference in concentration index between the pre- and 
post-ACA periods. Decomposition analysis of the concentration index was used to 
determine the impact of a range of sociodemographic variables on the disparity in 
colonoscopy use. Decomposition analysis is based on partitioning of total disparity into 
the precise disparities observed by each individual factor (van Doorslaer, Koolman et al. 
2004). A logistic regression is applied with a linear estimation to allow for the correct 
decomposition. The following equation shows the linear estimation of the logistic results 
where β𝑘
𝑛  are the average partial effects of each variable (𝑥) – yielding the likelihood of 
a screening colonoscopy (𝑦).         





The following equation shows the decomposition analysis comprised of average 
partial effects of each 𝑥 as well as their means and individuals concentration index. In 
this equation, the first expression shows the contribution of equivalized income, the 
second expression shows effects of other socio-demographic variables perceived to 

















We presented CIs prior to the ACA policy change (2008 and 2010) and after ACA 
implementation (2012, 2014, and 2016). We identified the largest determinant of 
disparity observed in pre-ACA years and post ACA years.  Positive values of the overall 
CIs suggest that colonoscopy use was concentrated among individuals with higher 
household incomes. CIs were broken down by confounder and represented as 
contributions to the overall income-related disparity in the use of colonoscopies with 
percentage contributions in brackets. The percentage contribution is attained by dividing 
the absolute contribution by the overall income-related disparity. We included age, sex, 
race and ethnicity, marital status, household income, educational attainment, region of 




Table 1 shows the descriptive statistics for pre-ACA years and post-ACA years in 
the total sample. The data set had 349,899 respondents aged 65 to 75. The majority of 
participants were female (59%), married (55%), exercised in the past 30 days (73%), and 
had a colonoscopy in the past 10 years (68%). The receipt of colonoscopy increased from 




Table 2 presents the descriptive characteristics of the respondents by colonoscopy 
use among insured elderly. Among the 349,899 insured elderly aged 65 to 75 years, 
236,275 (67%) indicated that they had received colonoscopies in the previous 10 years. 
The receipt of colonoscopy was highest among those aged 69-70 (68%). The receipt of 
colonoscopy was more prevalent among high income than those with low incomes (77% 
vs. 46%; p <.0001). About 74% of those graduated from college had colonoscopies 
compared to 53% of those who did not graduate from high school (74% vs. 53%; p 
<.0001). The receipt of colonoscopy was slightly higher among the respondents who 
exercised in the past 30 days than those who did not (70% vs. 61%; p <.0001). In 
addition, colonoscopy was more prevalent among former smokers or those never smoked 
than the current smokers (70% and 68% vs. 53%; p<.0001).  
Table 3 presents the decomposition of CIs in the use of colonoscopy in pre-ACA 
and post-ACA years. Elasticity values in the first column shows the sensitivity of 
colonoscopy use for each of the factors. The CI for each factor is presented in the second 
column, which shows the distribution of each factor by income levels. It tests the levels 
of influence for each factor according to income level. From pre-ACA to post-ACA 
years, overall CIs decreased from 0.1935 to 0.1813. Positive values of the overall CIs 
suggest that colonoscopy use was more concentrated among individuals with higher 
household incomes. For example, a positive value for educational attainment (education – 
attended college or graduated from college) in Table 3 indicates that educational 
attainment has a pro-rich distribution. Lastly, the final two columns of Table 3 present, 
respectively, the absolute and percentage contributions to overall income-related disparity 




the partial concentration index for each of the factors, so it depends both on the impact of 
each variable on the use of colonoscopy, and on its unequal distribution by household 
income. The positive absolute contribution of a factor indicates that the factor contributes 
to the measured pro-rich disparities in the use of colonoscopies. The percentage 
contribution can be obtained by dividing the absolute contribution by the overall income-
related disparity. The highest income group was consistently the largest contributor to 
disparity in the use of colonoscopies in both pre-ACA (54%) and in post-ACA years 
(79%). The highest income and highest educational attainment were the major 
contributors to the existing disparity in the use of colonoscopies. Having a college degree 
contributed approximately 31% to the observed CI for the use of colonoscopies in pre-
ACA years and 21% to CI in post-ACA years. Physical exercise in the previous 30 days 
and being a non-smoker positively contributed to colonoscopy disparity in both the pre-
ACA and post-ACA years.  
The concentration indices (CIs) for colonoscopy use in Figure 2 highlight the 
income-related. The positive values of the CI observed suggest that colonoscopy use has 
been more prevalent among the higher income individuals and the CI value has declined 




The aim of this study was to compare changes in income-related disparities in 




that affect the income-related disparities. Our concentration indices imply that significant 
income-related disparity in the use of colonoscopies exists among elderly insured 
individuals in the age group 65 to 75, and that disparities in the use of colonoscopy 
lessened after the implementation of ACA. A plausible explanation for the observed 
decline in disparities may be due to the reduction in cost-sharing. The results are 
consistent with the findings of an earlier study which found that the expansions in the 
coverage of CRC screening are associated with reductions in disparities (Hamman and 
Kapinos 2015).  
We found that income and educational attainment were the major contributors of 
disparity in the use of colonoscopies. Decomposition analysis show that the highest 
income group was consistently the largest contributor to disparity in pre-ACA (54%) and 
post-ACA years (79%) and having a college degree contributed approximately 31% to 
the observed disparities in pre-ACA years and 21% in post-ACA years. The previous 
study that identified income and educational attainment as the most important factors 
affecting observed disparity among insured population aged 50 to 64 years indicates that 
lower income and educational attainment together accounted for 59% of the explained 
disparity (Hamman and Kapinos 2015). Consistent with our study, a previous study 
examining the cervical cancer screening across 67 countries showed that income and 
educational attainment are the key determinants of disparities in uptake despite the 
existence of national policy assuring equal access to preventive services (McKinnon, 
Harper et al. 2011). Since income is such a significant contributor, policy makers should 
focus on strategies to identify how to improve access to screening services by poorer 




possible that accessing services, especially preventive services, involves higher 
opportunity cost for the poorer individuals than for richer individuals.  In the short-run, 
eliminating the remaining difference in cost-sharing between screening and therapeutic 
colonoscopies could be an approach for reducing disparities in the use of colonoscopies 
among Medicare beneficiaries (Hamman and Kapinos 2015). 
In this analysis, we found that colonoscopy use has remained pro-rich even after 
the introduction of ACA (CIs: 0.1935 in pre-ACA years to 0.1813 in post-ACA years). 
Our literature review did not find similar studies in the USA although few international 
studies can be used for comparing our results (Burns, Walsh et al. 2012, Walsh, Silles et 
al. 2012, Carrieri and Wuebker 2013, Kim and Hwang 2016). To better understand how 
the values of CIs in this study differ from other studies, we compared the CI values with 
available international studies. A number of studies found pro-rich disparities in CRC 
screening uptake in England (CI: 0.164), Ireland (CI: 0.070), and Korea (CI: 0.131) 
although the CI values are lower than what was obtained for the US elderly population. In 
addition, some studies reported pro-rich disparities in prostate cancer screenings in 
Ireland (CIs: 0.169 in the 40-54 age group, 0.157 in the 55-69 age group, 0.230 in the 70 
and over age group), gastric cancer screening (CI: 0.132) in Korea, mammography use 
(CI:0.144) in France, and mammography use (CI:0.125) in Germany. Again, the CI 
values are smaller than what we found in our empirical analysis. Lower disparity in 
countries with national health insurance programs is expected but the existence of 
disparity even in these countries point to the importance of examining other factors 
associated with socioeconomics that directly or indirectly lower access to preventive 




will be useful to analyze the proximate factors that have allowed other countries to 
achieve much lower disparity. Disparity in the use of colonoscopies still persists in the 
USA after the implementation of ACA in the US implying that coverage of screening 
programs by health insurance is one of the important steps towards reducing disparity but 
insurance coverage alone will not be sufficient to reduce the disparity by a significant 
extent. One plausible explanation is that cancer screening uptake may be influenced by 
other factors that are correlated with income. For instance, low income individuals may 
have lower physical access due to distance or face greater restrictions in their work to 
leave income earning activities for one full day. The loss of income due to absences from 
work may also be higher for the poorer groups as they are more likely to be employed on 
hourly basis. One study assessed the patterns and reasons for missed work related to 
colonoscopies and found that 34% of working individuals missed work for more than one 
day when they had their screenings scheduled on a Tuesday, Wednesday, or Thursday. 
This study also found that 32% took the previous day off as well mainly for the need for 
bowel preparation, 10% took the day after off, primarily as a precautionary measure after 
sedation rather than in response symptoms, and 9% took both days off. Moreover, 
colonoscopy procedures require a significant amount of time investment from friends and 
family members. 45% of individuals had friends or family members who also took time 
off work for the procedure (Dong, Kalmaz et al. 2011). These costs, to some extent, can 
be diminished through patient education on the procedure, and by scheduling 
colonoscopies on Mondays and Fridays (Dong, Kalmaz et al. 2011).  
Compared to traditional regression analysis, CI has its strengths and limitations. 




are not likely to be biased by the small sample sizes present in some subgroups. Another 
strength is that CI is especially sensitive to changes in socio-economic distribution. The 
primary limitation of CI is that it can only be applied when a strict ranking of households 
is available using a valid measure of socioeconomic status.  
Despite these limitations, this study provides evidence of changes in income-
related disparities in colonoscopy use among insured elderly from pre-ACA years to post-
ACA years. Our findings indicate that the ACA’s removal of financial barriers may have 
contributed towards observed decrease in the disparity of colonoscopy use. Interventions 
aimed at reducing disparities should focus on improving screening in populations with 
relatively low income and education. Further studies are needed to identify the barriers 
that prevent low-income and low-educational attainment individuals from seeking 
colonoscopy despite Medicare’s waiver of Part B deductibles for all colonoscopies and 
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Table 4.4 Characteristics of Survey Participants Aged 65 to 75 Years: Behavioral Risk Factor Surveillance 
System (BRFSS), 2008-2016 
  Total   Pre-ACA   Post ACA  
Characteristic  N  
 
Weighted %  
 N  
 
Weighted %  
 N  
 
Weighted %  
Total   349,899               100.0    125,577               100.0    224,322               100.0  
Age (years)       
65-66     78,424                 23.0      27,686                 22.7      50,738                 23.2  
67-68     72,261                 20.7      25,928                 20.5      46,333                 20.8  
69-70     65,746                 18.6      22,953                 17.9      42,793                 18.9  
71-72     56,989                 15.9      20,739                 16.3      36,250                 15.7  
73-75     76,479                 21.8      28,271                 22.6      48,208                 21.4  
Sex       
Male   144,628                 48.4      49,856                 48.0      94,772                 48.6  
Female   205,271                 51.6      75,721                 52.0    129,550                 51.4  
Race/ethnicity       
Non-Hispanic White   300,176                 78.7    107,573                 79.4    192,603                 78.3  
Non-Hispanic Black     23,541                   9.2        8,262                   8.6      15,279                   9.5  
Hispanic     11,393                   7.1        4,523                   7.1        6,870                   7.1  
Other     14,789                   5.1        5,219                   5.0        9,570                   5.2  
Married    191,812                 62.9      67,832                 65.7    123,980                 61.4  
Region of Residence       
Northeast     63,156                 17.9      21,448                 18.3      41,708                 17.7  
Midwest     83,992                 22.2      27,263                 22.1      56,729                 22.3  
South   117,730                 37.6      45,098                 37.6      72,632                 37.6  
West     85,021                 22.3      31,768                 22.0      53,253                 22.4  
Household income       
Less than $10,000     14,258                   4.1        6,171                   4.6        8,087                   3.9  
$10,000 to less than $15,000     23,717                   6.1        9,974                   6.4      13,743                   6.0  
$15,000 to less than $20,000     30,639                   8.3      12,442                   8.8      18,197                   8.1  
$20,000 to less than $25,000     41,080                 10.9      16,334                 11.7      24,746                 10.5  
$25,000 to less than $35,000     51,045                 14.0      20,179                 15.2      30,866                 13.3  
$35,000 to less than $50,000     61,885                 17.6      22,442                 17.8      39,443                 17.5  
$50,000 to less than $75,000     55,472                 16.5      17,758                 15.6      37,714                 16.9  
$70,000 or more     71,803                 22.5      20,277                 20.0      51,526                 23.8  
Education       
Did not graduate high school     28,997                 12.4      13,251                 11.4      15,746                 12.9  
Graduated High School   107,851                 30.3      43,068                 32.2      64,783                 29.2  
Attended College     92,346                 28.3      31,705                 24.3      60,641                 30.5  
Graduated from College   120,705                 29.0      37,553                 32.0      83,152                 27.4  




    
Yes   236,275                 67.2      78,958                 63.5    157,317                 69.2  
No   113,624                 32.8      46,619                 36.5      67,005                 30.8  
Exercise in past 30 days 




Yes   254,285                 72.2      89,570                 72.2    164,715                 72.2  
No     95,614                 27.8      36,007                 27.8      59,607                 27.8  
Smoking Status 
      
Current smoker     40,547                 11.2      15,127                 11.1      25,420                 11.3  
Former smoker   149,275                 44.0      55,012                 44.9      94,263                 43.5  




Table 4.5 Descriptive characteristics of the respondents by colonoscopy use among insured elderly aged 65 to 
75 Years, 2008-2016 
Variables 
 Total  
 Colonoscopy Uptake  
P-value  Yes   No  
 N   %   N   %   N   %  
Age (years)        
65-66     78,424      22.4      52,092      65.5      26,332        34.5  <.0001 
67-68     72,261      20.7      49,065      67.7      23,196        32.3   
69-70     65,746      18.8      44,776      67.9      20,970        32.1   
71-72     56,989      16.3      38,826      67.8      18,163        32.2   
73-75     76,479      21.9      51,516      67.3      24,963        32.7   
Sex        
Male   144,628      41.3      97,734      67.0      46,894        33.0  0.2031 
Female   205,271      58.7    138,541      67.4      66,730        32.6  
 
Race/ethnicity        
Non-Hispanic White   300,176      85.8    205,396      69.0      94,780        31.0  <.0001 
Non-Hispanic Black     23,541        6.7      15,638      67.2        7,903        32.8   
Hispanic     11,393        3.3        6,539      54.0        4,854        46.0   
Other     14,789        4.2        8,702      57.7        6,087        42.3   
Married    191,812      54.8    137,617      70.3      54,195        29.7  <.0001 
Region of Residence        
Northeast     63,156      18.1      44,832      70.2      18,324        29.8  <.0001 
Midwest     83,992      24.0      56,513      68.3      27,479        31.7   
South   117,730      33.7      79,992      68.0      37,738        32.0   
West     85,021      24.3      54,938      62.2      30,083        37.8   
Household income        
Less than $10,000     14,258        4.1        7,015      46.0        7,243        54.0  <.0001 
$10,000 to less than $15,000     23,717        6.8      12,602      52.4      11,115        47.6   
$15,000 to less than $20,000     30,639        8.8      17,438      56.0      13,201        44.0   
$20,000 to less than $25,000     41,080      11.7      25,215      61.5      15,865        38.5   
$25,000 to less than $35,000     51,045      14.6      33,674      65.7      17,371        34.3   
$35,000 to less than $50,000     61,885      17.7      43,352      69.4      18,533        30.6  
 
$50,000 to less than $75,000     55,472      15.9      41,231      73.6      14,241        26.4   
$70,000 or more     71,803      20.5      55,748      76.5      16,055        23.5   
Education        
Did not graduate high school     28,997        8.3      15,109      53.1      13,888        46.9  <.0001 
Graduated High School   107,851      30.8      68,862      64.7      38,989        35.3   
Attended College     92,346      26.4      62,647      69.0      29,699        31.0   
Graduated from College   120,705      34.5      89,657      74.0      31,048        26.0  
 
Exercise in past 30 days 
      
 
No     95,614      27.3      58,488      60.9      37,126        39.1  <.0001 
Yes   254,285      72.7    177,787      69.6      76,498        30.4   
Smoking Status 
      
 
Current smoker     40,547      11.6      21,566      53.4      18,981        46.6  <.0001 
Former smoker   149,275      42.7    104,426      70.0      44,849        30.0   
Never smoked   160,077      45.8    110,283      67.8      49,794        32.2   





Table 4.6 Decomposition Analysis of participation of colonoscopy among Insured Elderly: BRFSS, 
2008-16 
Variables 















Age (years)     
 
   
65-66 1.000    1.000    










0.001 -0.251 0.005 
-











Sex         











Race/ethnicity         














0.097 0.002 0.799 -0.004 
-




0.017 0.000 0.113 -0.004 
-
0.002 0.000 0.021 
Marital status         




0.409 0.020 10.500 -0.012 
-
0.434 0.021 11.673 
Region of Residence         




0.015 0.000 0.143 -0.003 
-




0.051 0.002 0.789 -0.002 
-




0.003 -1.648 -0.017 0.066 
-
0.004 -2.424 
Household income         
Less than $10,000 1.000    1.000    








































$35,000 to less than 
$50,000 0.028 0.078 0.009 4.490 0.027 0.008 0.001 0.460 
$50,000 to less than 
$75,000 0.030 0.277 0.033 17.235 0.032 0.241 0.030 16.792 
$70,000 or more 0.041 0.641 0.104 53.763 0.049 0.725 0.143 78.640 




Did not graduate high 
school 1.000    1.000    










Attended College 0.017 0.018 0.001 0.618 0.021 0.051 0.004 2.367 
Graduated from College 0.031 0.471 0.059 30.554 0.024 0.413 0.039 21.414 
Exercise in past 30 days         
No 1.000    1.000    
Yes 0.033 0.206 0.027 13.913 0.031 0.217 0.027 14.760 
Smoking Status         
Current smoker 1.000    1.000    
Former smoker 0.058 0.072 0.017 8.694 0.051 0.051 0.010 5.746 
Never smoked 0.044 0.026 0.005 2.377 0.042 0.057 0.010 5.261 

















































Cumulative proportion of population by SES rank




























SUMMARY, IMPLICATIONS, AND RECOMMENDATIONS 
 
 
The results of this study indicated that the use of colonoscopies increased among 
the elderly insured after the implementation of the ACA cost-sharing rule for preventive 
services. The receipt of colonoscopies among the elderly insured increased from 64% in 
pre-ACA years to 69% in post-ACA years. After controlling for a number of individual 
and geographic factors, we found that elderly insured in the age group 65 to 75 years 
were 1.15 times more likely to be up-to-date with colonoscopy screenings than they were 
before implementation of the ACA. Although the analysis could not incorporate out-of-
pocket expenses directly into the model due to lack of data, it is likely that the increase in 
colonoscopy uptake observed in the post-ACA years was due to reduction in cost-
sharing. Increased coverage of colonoscopies appeared to be more pronounced among 
elderly insured who were less educated and in lower household income groups. In fact, 
increases in colonoscopy uptake were greatest among the lower income and lower 
education groups when comparing pre-ACA percentages to post-ACA percentages.  
However, even with higher coverage of colonoscopies after ACA implementation, only 
about half of the elderly insured in the age group 65-75 years with a household income 
less than $15,000 received a recommended colonoscopy. In fact, post-ACA 




had received a colonoscopy in the last 10 years. Even after significant reductions in out-
of-pocket expenses for colonoscopy receipt, the coverage of colonoscopies remains  
suboptimal; it is much lower than the national goal of 80% by 2018 and the HP2020 goal 
of 71%. To achieve a higher rate of progress toward the national goal, we must identify 
specific approaches that encourage socioeconomically disadvantaged elderly to seek 
colonoscopies. 
However, we must stress again that our study did find a significant increase in 
colonoscopy use among elderly insured with lower socioeconomic status after 
implementation of the ACA. The increase may, in part, have been due to the removal of 
out-of-pocket costs, since previous studies found that financial barriers reduced coverage 
of cancer screening (Busch, Barry et al. 2006, Goodwin and Anderson 2012, Hamman 
and Kapinos 2015), and colonoscopies are expensive (Pyenson, Scammell et al. 2014). It 
is also possible that the increase in the receipt of colonoscopies among lower 
socioeconomic groups reflected both the continued increase of nationwide trends that and 
the proliferation of private health plans (Klabunde, Cronin et al. 2011, Shapiro, Klabunde 
et al. 2012, Wernli, Hubbard et al. 2014). The increase in CRC screenings was clearly 
universal across socioeconomic status and was not limited to subjects with lower income 
and lower levels of education. However, despite the improvements in colonoscopy uptake 
over the years, the poorest and the most socially disadvantaged groups represented the 
highest potential for improvement, given their relatively low rates of colonoscopy use. To 
achieve the target screening rate, policy makers must use additional interventions beyond 




Our study results in the second manuscript suggested a significant income-related 
disparity in the use of colonoscopies among the elderly insured aged 65 to 75, and that 
disparities in colonoscopy use were lessened after the implementation of the ACA. We 
found that income and educational attainment levels were the major contributors to the 
existing disparity in the use of colonoscopies. Decomposition showed that the highest 
income group was consistently the largest contributor to the disparity in pre-ACA 
colonoscopy receipt (54%) and in post-ACA colonoscopy receipt (79%), and that having 
a college degree contributed approximately 31% to the observed disparities in pre-ACA 
years and 21% in post-ACA years.  
Since income appears to be such a significant factor, policy makers should focus 
on the further reduction of financial barriers in colonoscopy use among the elderly 
insured. Eliminating cost-sharing for therapeutic colonoscopies could be the next policy 
reform to be considered in improving adherence to CRC screening guidelines (Hamman 
and Kapinos 2015). 
Policy makers must also consider non-medical costs in order to improve screening 
rates more rapidly. Cost is not the only barrier to receipt of colonoscopies. Other barriers 
include perceived loss of utility associated with bowel preparation prior to the test, 
logistical challenges, lack of a physician’s recommendation for CRC screening, and 
belief that CRC screening is unimportant or unnecessary (Benarroch-Gampel, Sheffield 
et al. 2012, Centers for Disease Control and Prevention 2013, Courtney, Paul et al. 2013, 
Howard, Guy et al. 2014, Ramdass, Petraro et al. 2014, Hamman and Kapinos 2015, 




Research has shown that patients’ perception of insurance coverage can deter 
them from receipt of CRC screening (Courtney, Paul et al. 2013, Zhao, Okoro et al. 
2018). This indicates a need for improved awareness of the ACA’s cost-sharing reduction 
provision among the elderly insured population. The Medicare program should ensure 
that all Medicare beneficiaries are aware of the new policy, which states that Part B 
provides screening colonoscopies with no deductible or coinsurance.  
Another problem to address is that individuals with low income and/or unstable 
employment may have more difficulty in leaving work to receive preventive services. A 
previous study assessed the patterns and reasons for missed work related to screening 
colonoscopies, and the researchers found that 34% of working individuals missed work 
more than one day when they had their screening on a Tuesday, Wednesday, or 
Thursday. According to the study, 32% of participants requested sick or vacation leave 
for the day prior to the screening, mainly in anticipation of the bowel preparation; 10% 
requested leave for the day after the procedure, primarily as a precautionary measure 
following sedation rather than in response to true symptoms; and 9% requested leave for 
both days.  
Finally, colonoscopy procedures require a significant amount of time investment 
from friends and family members. 45% of individuals had friends or family members 
who also took leave from work because of the procedure (Dong, Kalmaz et al. 2011). All 
these non-medical costs may be diminished through patient education about bowel 
preparation and what to expect before and after the procedure, and by scheduling more 




Researchers and policy makers have studied the effects of cost-sharing reductions 
on the utilization of preventive health care in great detail, but surprisingly, only a few 
studies have assessed the effect of cost-sharing reductions on colonoscopies among 
elderly insured (including Medicare beneficiaries), following the implementation of the 
ACA (Hamman and Kapinos 2015, Cooper, Kou et al. 2016). The few studies that have 
examined this issue used a very short time-frame beginning with the implementation of 
the ACA, so they may have underestimated the effects of the ACA cost-sharing 
reduction. Furthermore, these studies yielded variable results concerning the receipt of 
colonoscopies following the changes in coverage post-ACA (Fedewa, Goodman et al. 
2015, Hamman and Kapinos 2015, Cooper, Kou et al. 2016); and they did not determine 
whether eliminating financial barriers to the receipt of colonoscopies might affect 
socioeconomically vulnerable Medicare beneficiaries more than it affected other groups. 
Moreover, these studies did not examine the ACA’s impact on screening disparities 
among the elderly insured. It is true that some of the socioeconomically vulnerable 
elderly may be enrolled in Medicaid; and in those cases, the individuals would have 
received colonoscopies with no out-of-pocket expenses in the pre-ACA years. However, 
this should not affect the results of our study significantly as almost all elderly are 
enrolled in Medicare and only a relatively small percentage are enrolled in Medicaid 
(meaning Medicaid only or dually eligible) (Grabowski, 2012). Thus, to address these 
gaps in current research, this study examined the changes in colonoscopy use among the 
elderly insured population, including Medicare beneficiaries, following the 




Previous studies found divergent results regarding post-ACA changes in CRC 
screenings among the elderly and Medicare beneficiaries (Fedewa, Goodman et al. 2015, 
Hamman and Kapinos 2015, Han, Robin Yabroff et al. 2015, Cooper, Kou et al. 2016). 
Some studies found an increase in the receipt of CRC screenings (Fedewa, Goodman et 
al. 2015, Hamman and Kapinos 2015), while others found no change in the use of any 
cancer screening procedure (Han, Robin Yabroff et al. 2015, Cooper, Kou et al. 2016). 
However, unlike these studies, our study had access to a longer time frame, which 
allowed us to examine the effects of ACA policy changes on colonoscopy use in greater 
detail. Using a longer time frame, and controlling for many other potential factors 
affecting colonoscopy uptake (including the availability of health care providers in the 
area – a variable never used before), we found a significant effect of policy change on 
colonoscopy use. The new supply-side variable showed us that the availability of GIs in a 
geographic area did affect the likelihood of receiving a colonoscopy within the 
recommended time frame. We also enhanced the body of evidence surrounding changes 
in income-related disparities in colonoscopy use among the elderly insured from pre-
ACA years to post-ACA years. Our findings indicate that the ACA’s removal of financial 
barriers may contribute to the observed decrease in the disparity of colonoscopy use. 
This study has several limitations. First, the BRFSS is based on self-reports, 
which may be subject to recall bias. True screening rates are more likely less than 50% 
for adults aged 50 or older (Paskett and Khuri 2015). Therefore, we faced a challenge in 
establishing an accurate level of CRC screenings; and we were unable to perform a cross-
check with medical records using current data (Ferrante, Ohman-Strickland et al. 2008, 




this type of survey, as less-healthy patients may not be included in the sample. Third, the 
BRFSS does not include information about actual out-of-pocket expenditures or other 
possible determinants of screening such as opportunity, cost of time or difficulty in 
scheduling colonoscopies. Fourth, this study could not distinguish between screening and 
diagnostic colonoscopies. Nonetheless, given the fact that around 40% of adults who 
should receive CRC screenings do not receive them (Joseph, King et al. 2012, Hamman 
and Kapinos 2015, Paskett and Khuri 2015), finding an increase in all types of 
colonoscopies as a result of the Affordable Care Act does suggest an improvement in 
CRC detection. Fifth, gastroenterologists are not the only providers of colonoscopy, and 
licensed providers vary by region (Benarroch-Gampel, Sheffield et al. 2012, Joseph, 
Meester et al. 2016). Sixth, there may be historical threats to validity. Increasing 
awareness over time and social norms in support of CRC may affect the rate of 
colonoscopy use. Seventh, this study could not assess public awareness of CRC. Finally, 
in 2011 BRFSS changed its weighting methodology with the inclusion of cellular phone-
only respondents. Cellular phone respondents are likely to be different from other 
respondents in terms of age and risk of CRC. Therefore, this additional approach of 
selecting respondents may have affected the sample of 2011 compared to samples from 
the pre-2011 period.  
In summary, our results confirmed that there was a statistically significant 
increase in colonoscopy use among the elderly insured aged 65 to 75 years after the 
implementation of the ACA. There was a significant income-related disparity in the use 
of colonoscopies among the insured elderly aged 65 to 75, and disparities in colonoscopy 




levels were the major contributors to those disparities which still exist. Although 
Medicare waived Part B deductibles for all colonoscopies and eliminated coinsurance for 
screening colonoscopies, individuals are still subject to out-of-pocket medical expenses 
for therapeutic colonoscopies (Hamman and Kapinos 2015). Our results indicate that the 
ACA’s reduction of financial barriers has improved usage of CRC screening, and further 
improvements will be possible if the costs associated with therapeutic colonoscopies can 
be reduced or eliminated. Policy makers should also try to understand other related 
expenses, both medical and non-medical, associated with the receipt of colonoscopies by 
the elderly (Dong, Kalmaz et al. 2011, Petryszyn, Kempinski et al. 2014). Reducing these 
costs will also help achieve the national target rate of colonoscopy use. Interventions 
aimed at reducing disparities should focus on improving screening in populations with 
low household incomes and low educational attainment. Moreover, our results indicate 
that greater provider supply has been associated with increased use of colonoscopies. An 
increased supply of providers may have little beneficial effect on race and ethnic 
disparities in the receipt of colonoscopies or on geographic disparities in the receipt of 
colonoscopies (Benarroch-Gampel, Sheffield et al. 2012, Eberth, Josey et al. 2017). 
Interventions should focus on improving screening in populations living in rural areas 
and among minorities. A recent study reported that the estimated colonoscopist capacity 
was sufficient to screen 80% of the eligible U.S. population (Joseph, Meester et al. 2016). 
However, colonoscopies vary in quality, and high-quality colonoscopies take 
considerably more time than that which the average physician spends on such a 




short-run alternatives may be possible, such as training primary care providers to conduct 
colonoscopies (Selby, Cornuz et al. 2016).  
The results of this study indicated that the use of colonoscopies increased among 
the elderly insured after the implementation of the ACA cost-sharing rule for preventive 
services. Reduction of financial barriers has been effective in improving CRC screening, 
and further reduction in financial barriers is likely to improve uptake of CRC screening in 
the future. The financial barriers are due not only to medical care costs but also to other 
non-medical expenses, and policy makers should consider how to improve access to 
preventive services by considering all the potential barriers to access. In general, 
lowering out-of-pocket expenses for colonoscopies has improved receipt of 
colonoscopies by all elderly groups; but the increase in coverage was higher for poorer 
individuals and individuals with low educational attainment. Therefore, reduction in out-
of-pocket expenses benefited the disadvantaged elderly population at a higher rate than 
other elderly groups.  
This study will contribute to advancing knowledge about the effect of reduction in 
cost-sharing on the receipt of colonoscopies among the elderly insured. It is critically 
important to know whether reduction of financial barriers alone can improve adherence to 
CRC screenings in order to achieve the national goal of 80% by 2018 target and the 
HP2020 goal of 71%. Reduction in financial expenses alone may not be enough to reach 
the goal, in which case these analyses will be able to indicate other policy options for 
improving coverage of colonoscopies. The study will provide scientific evidence on 
effect of cost-sharing reduction on the receipt of colonoscopies among the elderly insured 




Under current law, Medicare waives coinsurance and deductibles for 
colonoscopies. However, when a polyp is discovered and removed, the procedure is 
reclassified as therapeutic for Medicare billing purposes and beneficiaries become 
responsible for paying 20% coinsurance. Therefore, Medicare beneficiaries may face 
unexpected out-of-pocket liabilities when a polyp is detected and removed during a 
colonoscopy. The Removing Barriers to Colorectal Cancer Screening Act of 2017 (H.R. 
1017/S. 479 worked to correct an oversight in current law that requires Medicare 
beneficiaries to cover the cost of their copayment for a free screening colonoscopy if a 
polyp was discovered and removed during the procedure. This study will provide 
scientific evidence regarding the benefits of cost-sharing reductions on the receipt of 
colonoscopies among Medicare beneficiaries, thus supporting the Congressional bill 
which proposes to close remaining Medicare loophole. As a next step, we will prepare a 
manuscript to submit for the American Journal of Public Health and then a second 
manuscript to submit to Medical Care. I will also share my findings, including policy 
implications, at the American Public Health Association annual meeting in 2018. Finally, 
this dissertation will lay a foundation for a grant I plan to pursue (from, for example, an 
R03 small research grant program) to conduct a more in-depth investigation of racial and 
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